To every girl and every woman, this word is provided: You are princess, You’re ambassador to the king , You’re a servant of the King, Jesus Christ is the king, Jesus is in your heart, You can befriend Jesus
A beautiful paper published by Eugene Braunwald
European Heart Journal, Volume 42, Issue 24, 21 June 2021, Pages 2327–2328, https://doi.org/10.1093/eurheartj/ehab264
To every girl and every woman, this word is provided: You are princess, You’re ambassador to the king , You’re a servant of the King, Jesus Christ is the king, Jesus is in your heart, You can befriend Jesus
A beautiful paper published by Eugene Braunwald
European Heart Journal, Volume 42, Issue 24, 21 June 2021, Pages 2327–2328, https://doi.org/10.1093/eurheartj/ehab264
Summary of the European Society of Cardiology of two recent guidelines of management of atrial fibrillation (2020) and supraventricular tachycardia (2019)
Guidelines to record your presentation- In the University, professors are requested to record their lectures not only with voice but with the physical appearance of the speaker. This is guide how to record by yourself
Speckle tracking echocardiography is a new, unique and evolving tool to assess the myocardial deformation which can detect LV systolic dysfunction much earlier than can be reflected in LVEF. The importance of defining predictors is to predict whom patient will be at risk for the deleterious effect of RV pacing on LV function, and who will need observation with possible upgrading to biventricular pacing.
Summary of the European Society of Cardiology of two recent guidelines of management of atrial fibrillation (2020) and supraventricular tachycardia (2019)
Guidelines to record your presentation- In the University, professors are requested to record their lectures not only with voice but with the physical appearance of the speaker. This is guide how to record by yourself
Speckle tracking echocardiography is a new, unique and evolving tool to assess the myocardial deformation which can detect LV systolic dysfunction much earlier than can be reflected in LVEF. The importance of defining predictors is to predict whom patient will be at risk for the deleterious effect of RV pacing on LV function, and who will need observation with possible upgrading to biventricular pacing.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Cardio egypt congress 2021 total program by hall uploaded by samir rafla
1. PROGRAM BY HALL
Abdeen
139
8:30
9:30
Abdeen
Hypertension Track Session "5" How should I treat? 2
Hypertension Track Session
Thu 18-2
*
Chairperson
Charl Boshra
Mohamed Abdelwahab Ezat
Mohamed Bordy
Taghreed Helal
1 8:30 8:42 12 min.
Ossama Sanad. Benha. Egypt
Diuretics Vs CCBs for initial combination therapy (on top of
RAASi). A guide to selection (Debate) -Dieurtic the best
139001
240
2 8:42 8:54 12 min.
Hesham Nasr. NHI. Egypt
Diuretics Vs CCBs for initial combination therapy (on top of
RAASi). A guide to selection (Debate) - CCB the best
139002
323
3 8:54 9:00 6 min.
Discussion. .
Discussion
139003
315
4 9:00 9:12 12 min.
Ahmed Galal. NHI. Egypt
Resistant Hypertension. Updated guidelines review (Achieving
control or changing the goal).
139004
506
5 9:12 9:15 3 min.
Discussion. .
Discussion
139005
315
6 9:15 9:27 12 min.
Ghada Sayed Youssef. Cairo. Egypt
New molecules for treating Resistant Hypertension... Novel
drugs
139006
111
7 9:27 9:30 3 min.
Discussion. .
Discussion
139007
315
Page | 1
Prepared by RM Solutions | www.rmsolutions.net
2. PROGRAM BY HALL
Abdeen
140
9:30
10:30
Abdeen
Diabetes and Cardiometabolic syndrome Track Session "4"
Cardiometabolic syndrome
Diabetes Track Session
Thu 18-2
*
Chairperson
Adel Abdelaziz
Adel El Etriby
Nada Hamed
Nawal Shawky
1 9:30 9:42 12 min.
Andreas Zirlik. . Germany
Hypertriglyceridemia and CVD risk…. A position statement
140001
511
2 9:42 9:45 3 min.
Discussion. .
Discussion
140002
315
3 9:45 9:57 12 min.
Mahfouz Elshahawy. . USA
Epicardial fat, a part of visceral obesity or a specific risk factor?
140003
378
4 9:57 10:00 3 min.
Discussion. .
Discussion
140004
315
5 10:00 10:12 12 min.
Fausto Pinto. . Portugal
Management of CVD risk in metabolic syndrome, Priorities
and algorithm
140005
438
6 10:12 10:15 3 min.
Discussion. .
Discussion
140006
315
7 10:15 10:30 15 min.
Discussion. .
General Discussion
140007
315
Page | 2
Prepared by RM Solutions | www.rmsolutions.net
3. PROGRAM BY HALL
Abdeen
141
10:30
11:30
Abdeen
HypertensionTrack Session "3" Secondary Hypertension
Hypertension Track Session
Thu 18-2
*
Chairperson
Anastasia Mihailidou
Hazem Farrag
Magdy Abdelsamie
Mahmoud Ali Soliman
Tarek Naguib
Waleed Abdou
1 10:30 10:45 15 min.
Sherif Wagdy. Alexandria. Egypt
Patients’ profile and when to suspect early?
141001
441
2 10:45 10:50 5 min.
Discussion. .
Discussion
141002
315
3 10:50 11:05 15 min.
Azza Zakaria El Eraky. Port Said. Egypt
Most seen scenarios in daily practice and the art of handling
investigations
141003
380
4 11:05 11:10 5 min.
Discussion. .
Discussion
141004
315
5 11:10 11:25 15 min.
Ali Mahmoud Kassem. Sohag. Egypt
Secondary Hypertension, chance of normalization of BP on
controlling the cause and overall prognosis, what literatures
say?
141005
640
6 11:25 11:30 5 min.
Discussion. .
Discussion
141006
315
Page | 3
Prepared by RM Solutions | www.rmsolutions.net
4. PROGRAM BY HALL
Abdeen
142
12:30
13:30
Abdeen
Cardiology! Medicolegal Prespectives
Medical Track Session
Thu 18-2
*
Chairperson
Aziz Madkour
Hassan Baky
Khaled Hussein
Mohamed Ossama
1 12:30 12:42 12 min.
Abdelmoty Kabbash. Tanta. Egypt
Can I make a claim for medical negligence?
142001
515
2 12:42 12:45 3 min.
Discussion. .
Discussion
142002
315
3 12:45 12:57 12 min.
Rabab El kelany. Tanta. Egypt
Medical Errors categorization and prophylactic strategy
142003
516
4 12:57 13:00 3 min.
Discussion. .
Discussion
142004
315
5 13:00 13:12 12 min.
Amal Saeed. Tanta. Egypt
Medical Negligence in cardiology: common pitfalls
142005
518
6 13:12 13:15 3 min.
Discussion. .
Discussion
142006
315
7 13:15 13:27 12 min.
Marwa Shaheen. Alexandria. Egypt
ي
والمستشف للطبيب القانونية المسؤولية
142007
517
8 13:27 13:30 3 min.
Discussion. .
Discussion
142008
315
Page | 4
Prepared by RM Solutions | www.rmsolutions.net
5. PROGRAM BY HALL
Abdeen
143
14:30
18:30
Abdeen
Research
Medical Track Session
Thu 18-2
*
1 14:30 15:15 45 min.
Noha Asem. Ministry assistant for research. Egyp
Translating Research Into practice
143001
431
2 15:15 15:45 30 min.
Ihab Yassin. NHI. Egypt
Overview of study Design
143002
519
3 15:45 16:30 45 min.
Mohamed Bendary. Cairo. Egypt
Basics of Biostatistics
143003
520
4 16:30 17:00 30 min.
TBA. .
Journal finders and metrics
143004
316
5 17:00 17:30 30 min.
TBA. .
Basics of Medical Writing
143005
316
6 17:30 18:30 60 min.
Mohamed Bendary. Cairo. Egypt
Workshop
143006
520
Page | 5
Prepared by RM Solutions | www.rmsolutions.net
6. PROGRAM BY HALL
Al Hambra 1
56
13:30
14:00
Al Hambra 1
Medtronic Parallel Symposium
Industry Sponsored Symposium Symposium
Mon 15-2
*
57
14:00
14:30
Al Hambra 1
Merck Parallel Symposium
Industry Sponsored Symposium Symposium
Mon 15-2
*
Chairperson
Maged Ramses
Sameh Shaheen
1 14:00 14:30 30 min.
Khaled Shokry. Military. Egypt
Royal Control
057001
168
58
14:30
15:00
Al Hambra 1
Habib “Marcyrl” Parallel Symposium
Industry Sponsored Symposium Symposium
Mon 15-2
*
Chairperson
Adel El Etriby
Hamza Kabil
Hosam Hasan
Mohamed El Setiha
Mohamed Ossama
Mohamed Sobhy
1 14:30 15:00 30 min.
Nabil Farag. Ain Shams. Egypt
The Newest NOAC in Egypt
058001
229
Page | 6
Prepared by RM Solutions | www.rmsolutions.net
7. PROGRAM BY HALL
Al Hambra 1
59
15:00
15:30
Al Hambra 1
Diabetes and Cardiometabolic Syndrome Track Session "2" New
era of antidiabetics!
Diabetes Track Session
Mon 15-2
*
Chairperson
Ahmad Mohamed Fathy
Ahmed Yehia
Alaa Etman
Khaled Shokry
Seif Kamal Abou Seif
Tarek Abdelghafar
1 15:00 15:12 12 min.
Sameh Emil. Military. Egypt
Position statement for SGLT2i and GLPi from cardiology
perceptive
059001
260
2 15:12 15:15 3 min.
Discussion. .
Discussion
059002
315
3 15:15 15:27 12 min.
Heba Sedrak. Cairo. Egypt
Combining antidiabetics together in cardiac patients, an
algorithm from diabetiologist
059003
377
4 15:27 15:30 3 min.
Discussion. .
Discussion
059004
315
Page | 7
Prepared by RM Solutions | www.rmsolutions.net
8. PROGRAM BY HALL
Al Hambra 1
61
15:30
16:30
Al Hambra 1
Hypertension Track Session "1" How should I treat? (Unusual
case scenarios in Hypertension {A}
Hypertension Track Session
Mon 15-2
*
Chairperson
Ahmed Shawky
Azza Zakaria El Eraky
Farid Doala
Fayez Fayek
Lotfy Hamed Abodahab
Nabil Gobran
1 15:30 15:42 12 min.
Timoor Mostafa Hassan. Tanta. Egypt
High systolic with low diastolic hypertension, How low is too
low??
061001
290
2 15:42 15:45 3 min.
Discussion. .
Discussion
061002
315
3 15:45 15:57 12 min.
Samy Nouh. Azhar. Egypt
Pseudo resistance, How to detect and treat
061003
383
4 15:57 16:00 3 min.
Discussion. .
Discussion
061004
315
5 16:00 16:12 12 min.
Samia Mahmoud Sharaf El Din. Tanta. Egypt
Autoimmune disease associated with hypertension, the
challenge of management
061005
384
6 16:12 16:15 3 min.
Discussion. .
Discussion
061006
315
7 16:15 16:27 12 min.
Ahmed Farghaly. NHI. Egypt
120/100 how should I manage?
061007
748
8 16:27 16:30 3 min.
Discussion. .
Discussion
061008
315
Page | 8
Prepared by RM Solutions | www.rmsolutions.net
9. PROGRAM BY HALL
Al Hambra 1
63
16:30
17:30
Al Hambra 1
Diabetes and Cardiometabolic| syndrome Track Session "1"
Dipping into T2DM
Diabetes Track Session
Mon 15-2
*
Chairperson
Hazem Khorshid
Khalid El Rabbat
Matta Nashid
Mohamed Saad Amin Elgammal
1 16:30 16:42 12 min.
Ibrahim Elabrashy. Cairo. Egypt
Remission of T2DM, an illusion or reality? And possible
consequences in CVD risk?
063001
393
2 16:42 16:45 3 min.
Discussion. .
Discussion
063002
315
3 16:45 16:57 12 min.
Ashraf Talat. Damietta. Egypt
T2DM in young and in elderly, is there any message from
diabetiologist to cardiologists?
063003
843
4 16:57 17:00 3 min.
Discussion. .
Discussion
063004
315
5 17:00 17:12 12 min.
Magdy Elmasry. Tanta. Egypt
Do T2DM drugs have CV benfit for Tye 1?
063005
178
6 17:12 17:15 3 min.
Discussion. .
Discussion
063006
315
7 17:15 17:27 12 min.
Inas Shaltout. Cairo. Egypt
Insulin therapy for cardiac patients, diabetiologist message to
cardiologist?
063007
347
8 17:27 17:30 3 min.
Discussion. .
Discussion
063008
315
Page | 9
Prepared by RM Solutions | www.rmsolutions.net
10. PROGRAM BY HALL
Al Hambra 1
68
12:30
13:00
Al Hambra 1
Ecco "Marcyrl" Parallel Symposium
Industry Sponsored Symposium Symposium
Tue 16-2
*
Chairperson
Hany Ragy
Hesham Salah Eldin
Mohamed Abdelghany
Mohamed Sobhy
Nabil Farag
1 12:30 12:45 15 min.
Nabil Farag. Ain Shams. Egypt
risk Reduction in Dyslipidemia Beyond LDL target/ Role of
Icosapent ethyl "EPA"
068001
229
2 12:45 13:00 15 min.
Mohamed Sobhy. Alexandria. Egypt
Are all "EPA-containing products "the same?!
068002
217
69
13:00
13:30
Al Hambra 1
Parallel Symposium - Sanofi
Industry Sponsored Symposium Symposium
Tue 16-2
*
Chairperson
Hamza Kabil
Mohamed Ossama
Sameh Shaheen
1 13:00 13:15 15 min.
Alaa Etman. NHI. Egypt
Perspectives of ACS management
069001
51
2 13:15 13:30 15 min.
Mohamed Zahran. Ain Shams. Egypt
Does optimization for maximum protection
069002
220
71
14:30
15:30
Al Hambra 1
Parallel Symposium - Novartis
Industry Sponsored Symposium Symposium
Tue 16-2
*
Page | 10
Prepared by RM Solutions | www.rmsolutions.net
11. PROGRAM BY HALL
Al Hambra 1
75
17:00
18:00
Al Hambra 1
Smoking Cessation
Smoking Track Session
Tue 16-2
*
Chairperson
Adel Shabana
Farid Doala
Maged Naeem
Mohamed Hamza Kabil
Talaat Elsayed
Waleed Abbas
1 17:00 17:12 12 min.
Hany Ragy. NHI. Egypt
Different Ways of Quitting Smoking?
075001
128
2 17:12 17:15 3 min.
Discussion. .
Discussion
075002
315
3 17:15 17:27 12 min.
Ehab Elkharat. . Egypt
Thirty Seconds could Save Life… The Simple Advice from
Healthcare Staff to Dialogue with a Smoking Patient
075003
410
4 17:27 17:30 3 min.
Discussion. .
Discussion
075004
315
5 17:30 17:42 12 min.
Mahmoud Othman. NHI. Egypt
Smoking Cessation and Cardiac Health (Risk Calculations)
075005
817
6 17:42 17:45 3 min.
Discussion. .
Discussion
075006
315
7 17:45 17:57 12 min.
Bassem Zarif. NHI. Egypt
Barriers of Quitting Smoking?
075007
85
8 17:57 18:00 3 min.
Discussion. .
Discussion
075008
315
80
12:30
13:00
Al Hambra 1
MSD Parallel Symposium
Industry Sponsored Symposium Symposium
Wed 17-2
*
Page | 11
Prepared by RM Solutions | www.rmsolutions.net
12. PROGRAM BY HALL
Al Hambra 1
81
13:00
13:30
Al Hambra 1
Biofactor “Marcyrl” Parallel Symposium
Industry Sponsored Symposium Symposium
Wed 17-2
*
Chairperson
Adel El Etriby
Hossam Kandil
Nabil Farag
1 13:00 13:15 15 min.
Ahmed Shawky. Ain Shams. Egypt
Why is dapagliflozin portfolio a game changer?
081001
46
2 13:15 13:30 15 min.
Ramez Guindy. Ain Shams. Egypt
Rosuvastatin/ Ezetimibe single pill combination; A high
Intensity Lipid Lowering Therapy
081002
487
83
14:30
15:00
Al Hambra 1
AstraZeneca Parallel Symposium
Industry Sponsored Symposium Symposium
Wed 17-2
*
Chairperson
Mansour Moustafa
Moamen Moaz
Soliman Ghareeb
Tarek Naguib
1 14:30 15:00 30 min.
Ahmed Magdi. NHI. Egypt
Hypertensive dyslipidemia patients, beyond control with
optimum protection
083001
34
84
15:00
15:30
Al Hambra 1
Pfizer Biopharmaceutical Parallel Symposium “Virtual"
Industry Sponsored Symposium Symposium
Wed 17-2
*
1 15:00 15:30 30 min.
Ihab Attia. Ain Shams. Egypt
The use of NOACs in special population patients
084001
422
Page | 12
Prepared by RM Solutions | www.rmsolutions.net
13. PROGRAM BY HALL
Al Hambra 1
90
12:30
13:00
Al Hambra 1
Pfizer Biopharmaceutical Parallel Symposium “Virtual”
Industry Sponsored Symposium Symposium
Thu 18-2
*
1 12:30 13:00 30 min.
Mohamed Sobhy. Alexandria. Egypt
The challenges for current practice for NOACs
090001
217
91
13:00
13:30
Al Hambra 1
Janseen Parallel Symposium
Industry Sponsored Symposium Symposium
Thu 18-2
*
Chairperson
Ahmed Nassar
Mohamed Ossama
1 13:00 13:30 30 min.
Nazzareno Galie. . Italy
Triple combination in PAH - Uptravi when and what to Expect
091001
869
93
14:30
15:00
Al Hambra 1
Liptis Parallel Symposium
Industry Sponsored Symposium Symposium
Thu 18-2
*
Chairperson
Hossam Kandil
1 14:30 15:00 30 min.
Adel El Etriby. Ain Shams. Egypt
SGLT2 inhibitors a new hope for heart failure treatment
093001
11
94
15:00
15:15
Al Hambra 1
Scientific Lecture "Endorsed by EvaPharma"
Industry Sponsored Symposium Symposium
Thu 18-2
*
Chairperson
Adel El Etriby
Magdy Abdelhamid
1 15:00 15:15 15 min.
Sameh Shaheen. Ain Shams. Egypt
AF: 10 Practice essential
094001
261
Page | 13
Prepared by RM Solutions | www.rmsolutions.net
14. PROGRAM BY HALL
Al Hambra 1-2
51
8:30
9:30
Al Hambra 1-2
Lipids and Atherosclerosis Session "4" Atherosclerosis
Lipids and Atherosclerosis Session
Mon 15-2
*
Chairperson
Ashraf Reda
Diaa Elmenshawy
Hamdy Soliman
Sameh Emil
Samir Rafla
1 8:30 8:42 12 min.
Galal Al-Kilany. . USA
Multimodality imaging in estimating CVD risk
051001
864
2 8:42 8:45 3 min.
Discussion. .
Discussion
051002
315
3 8:45 8:57 12 min.
Ahmed Aly Elaskary. Sohag. Egypt
Inflammation the co-player in atherosclerosis, An update
051003
374
4 8:57 9:00 3 min.
Discussion. .
Discussion
051004
315
5 9:00 9:12 12 min.
Tamer Elashkar. NHI. Egypt
Targeting plaque regression or plaque stabilization?
051005
359
6 9:12 9:15 3 min.
Discussion. .
Discussion
051006
315
7 9:15 9:27 12 min.
Nabil Farag. Ain Shams. Egypt
Non-culprit plaques in ACS, Do they have a special care?
051007
229
8 9:27 9:30 3 min.
Discussion. .
Discussion
051008
315
Page | 14
Prepared by RM Solutions | www.rmsolutions.net
15. PROGRAM BY HALL
Al Hambra 1-2
52
9:30
10:30
Al Hambra 1-2
Heart Failure Track | Session "3" Heart Failure & Diabetes
Heart Failure Track Session
Mon 15-2
*
Chairperson
Alaa Mohamed Ibrahim Ali
Bassem Zarif
Magdy Abdelhamid
Mohamed Aboel Kassem
Mohamed Korim
Osama Louis
1 9:30 9:45 15 min.
Khaled Leon. NHI. Egypt
Heart failure in diabetics, is it a different entity?
052001
166
2 9:45 9:50 5 min.
Discussion. .
Discussion
052002
315
3 9:50 10:05 15 min.
Francesco Cosentino. . Italy
SGLT2i, Class effect or different individuals…… Data from new
trials
052003
362
4 10:05 10:10 5 min.
Discussion. .
Discussion
052004
315
5 10:10 10:25 15 min.
Petar Seferovic. . Serbian
Treat of Heart Failure in diabetics! Drug treatment and beyond
052005
363
6 10:25 10:30 5 min.
Discussion. .
Discussion
052006
315
Page | 15
Prepared by RM Solutions | www.rmsolutions.net
16. PROGRAM BY HALL
Al Hambra 1-2
53
10:30
11:30
Al Hambra 1-2
Heart Failure Track | Session "1" A comprehensive review for
“chronic heart failure Diagnosis”
Heart Failure Track Session
Mon 15-2
*
Chairperson
Aly Saad
Amr Zaki
Doaa A Fouad
Ehab Abdelwahab Hamdy
Ghada Ibrahim Mohamed
Sameh Bakhom
1 10:30 10:45 15 min.
Abdalla Al Agha. Cairo. Egypt
The role of Imaging: CMR
053001
1
2 10:45 10:50 5 min.
Discussion. .
Discussion
053002
315
3 10:50 11:05 15 min.
Leila Abid. . Tunisia
The role of Imaging: Echo
053003
368
4 11:05 11:10 5 min.
Discussion. .
Discussion
053004
315
5 11:10 11:25 15 min.
Magdy Abdelhamid. Cairo. Egypt
The role of Biomarkers
053005
176
6 11:25 11:30 5 min.
Discussion. .
Discussion
053006
315
Page | 16
Prepared by RM Solutions | www.rmsolutions.net
17. PROGRAM BY HALL
Al Hambra 1-2
54
11:30
12:30
Al Hambra 1-2
Coronary Track| Session "1" Antiplatelets therapy. The quest for
perfect remedy - All case based
Coronary Track Session
Mon 15-2
*
Chairperson
Hosam Hasan
Moustafa Mokarrab
Ramzy Elmawardy
Tarek Kafafy
Yasser Elbarbary
1 11:30 11:42 12 min.
Yasser Elsayed. Azhar. Egypt
The 2nd antiplatelet choice in 2021
054001
371
2 11:42 11:45 3 min.
Discussion. .
Discussion
054002
315
3 11:45 11:57 12 min.
Adel Hamdy Mahmoud. Minia. Egypt
SAPT or DAPT in chronic AF patients?
054003
372
4 11:57 12:00 3 min.
Discussion. .
Discussion
054004
315
5 12:00 12:12 12 min.
Sherif Hussein. MUST. Egypt
The mechanical valve patient & the post revascularization
therapy challenge
054005
273
6 12:12 12:15 3 min.
Discussion. .
Discussion
054006
315
7 12:15 12:27 12 min.
Wael El Naggar. Cairo. Egypt
When duration counts? Prolonged DAPT, the new evidence
054007
373
8 12:27 12:30 3 min.
Discussion. .
Discussion
054008
315
Page | 17
Prepared by RM Solutions | www.rmsolutions.net
18. PROGRAM BY HALL
Al Hambra 1-2
55
12:30
13:30
Al Hambra 1-2
Lipids and Atherosclerosis Session "1" Lipids linked CVD risk, An
Update
Lipids and Atherosclerosis Session
Mon 15-2
*
Chairperson
Ahmed Aly Elaskary
Ayman Saleh
Hesham Salah Eldin
Khaled Eltohamy
Mohamed Zaki
1 12:30 12:42 12 min.
Hatem Elsokkary. Tanta. Egypt
CVD risk stratification to plan lipids management, panoramic
view from different guidelines
055001
131
2 12:42 12:45 3 min.
Discussion. .
Discussion
055002
315
3 12:45 12:57 12 min.
Mohamed Sobhy. Alexandria. Egypt
Lp(a) … Although a lot of data available, yet not an
independent risk factors?!
055003
217
4 12:57 13:00 3 min.
Discussion. .
Discussion
055004
315
5 13:00 13:12 12 min.
Yaser Huzayen. Ain Shams. Egypt
Non-HDL is it just another way to calculate LDL or different
parameter?
055005
752
6 13:12 13:15 3 min.
Discussion. .
Discussion
055006
315
7 13:15 13:27 12 min.
Elsayed Farag. Zagazig. Egypt
Triglycerides and CVD risk, the unsettled issue?!
055007
95
8 13:27 13:30 3 min.
Discussion. .
Discussion
055008
315
Page | 18
Prepared by RM Solutions | www.rmsolutions.net
19. PROGRAM BY HALL
Al Hambra 1-2
65
8:30
9:30
Al Hambra 1-2
Coronary Track Session "2" How should I treat?
Coronary Track Session
Tue 16-2
*
Chairperson
Mohamed Mahmoud Ahmed
Mohamed Saad Amin Elgammal
Montaser M Alcekelly
Tarek Mohamed Abdelrahman
1 8:30 8:42 12 min.
Maged Al Abbady. NHI. Egypt
How to assess coronary ischemia, choosing the right test
065001
313
2 8:42 8:45 3 min.
Discussion. .
Discussion
065002
315
3 8:45 8:57 12 min.
Antoine Lafont. . France
Highly positive noninvasive testing in minimally symptomatic
patient?
065003
403
4 8:57 9:00 3 min.
Discussion. .
Discussion
065004
315
5 9:00 9:12 12 min.
Ahmed Bendary. Benha. Egypt
Multivessel revascularization in 2021, from scoring to
individualized care
065005
25
6 9:12 9:15 3 min.
Discussion. .
Discussion
065006
315
7 9:15 9:27 12 min.
Abdelrahman Elbokary. NHI. Egypt
When pregnancy becomes the problem (A rare case scenario)
065007
5
8 9:27 9:30 3 min.
Discussion. .
Discussion
065008
315
Page | 19
Prepared by RM Solutions | www.rmsolutions.net
20. PROGRAM BY HALL
Al Hambra 1-2
66
9:30
10:30
Al Hambra 1-2
Heart FailureTrack Session "2" An algorithm of management of
“Chronic Heart Failure: Comorbidities”
Heart Failure Track Session
Tue 16-2
*
Chairperson
Hossam Kandil
Magdy Elmasry
Mahmoud Hassan shah
Montaser M Alcekelly
Salah Atta
Walaa Farid
1 9:30 9:42 12 min.
Sameh Shaheen. Ain Shams. Egypt
Debate: Do co-morbidities affect directly the outcome in HF
patients? Pro: Comorbidities directly affect outcome in HF
066001
261
2 9:42 9:54 12 min.
Atef El Bahry. Port Said. Egypt
Debate: Do co-morbidities affect directly the outcome in HF
patients? Contra: Comorbidities are just consequences or
bystanders and not affect outcome directly
066002
407
3 9:54 10:04 10 min.
Discussion. .
Discussion
066003
315
4 10:04 10:24 20 min.
Hadi Skouri. . Lebanon
Cancer: Cardio toxicity induced heart failure, new data
066004
406
5 10:24 10:30 6 min.
Discussion. .
Discussion
066005
315
Page | 20
Prepared by RM Solutions | www.rmsolutions.net
21. PROGRAM BY HALL
Al Hambra 1-2
67
10:30
11:30
Al Hambra 1-2
Lipids and Atherosclerosis Trak Session "3" Lipids objectives in
cardio-metabolic syndrome
Lipids and Atherosclerosis Session
Tue 16-2
*
Chairperson
Gamal Aboul Nasr
Hossam El Masry
Khaled Elkhashab
Samir Rafla
1 10:30 10:42 12 min.
Gamela Nasr. Suez Canal. Egypt
Best CVD risk assessment for patients with metabolic
067001
110
2 10:42 10:45 3 min.
Discussion. .
Discussion
067002
315
3 10:45 10:57 12 min.
Ashraf Reda. Menofia. Egypt
Icosapent Ethyl …evidence data and position statement
067003
71
4 10:57 11:00 3 min.
Discussion. .
Discussion
067004
315
5 11:00 11:12 12 min.
Hesham Salah Eldin. Cairo. Egypt
Fibrates……A position statement in the armamentarium of
CVD prevention
067005
337
6 11:12 11:15 3 min.
Discussion. .
Discussion
067006
315
7 11:15 11:27 12 min.
Ali Eltaher. Sohag. Egypt
Lipid management in NAFLD
067007
409
8 11:27 11:30 3 min.
Discussion. .
Discussion
067008
315
Page | 21
Prepared by RM Solutions | www.rmsolutions.net
22. PROGRAM BY HALL
Al Hambra 1-2
74
15:30
17:00
Al Hambra 1-2
Coronary Track Session "3" How should I treat? II
Coronary Track Session
Tue 16-2
*
Chairperson
Gamal Aboul Nasr
Hossam Mesbah
Khaled Hussein
Waleed Elawady
1 15:30 15:42 12 min.
Hosam Hasan. Assiut. Egypt
Building up Optimal Medical Therapy (OMT) for chronic
coronary syndrome patient, between inertia and true failure
074001
146
2 15:42 15:45 3 min.
Discussion. .
Discussion
074002
315
3 15:45 15:57 12 min.
Hazem Khamis. Military. Egypt
FFR guided PCI for elective cases, between preference and
obligation.? Long-term outcome data
074003
135
4 15:57 16:00 3 min.
Discussion. .
Discussion
074004
315
5 16:00 16:12 12 min.
Ayman Aboul Magd. Azhar. Egypt
The dilemma of repeated revascularization, between bad
initial choices to more complicated management
074005
76
6 16:12 16:15 3 min.
Discussion. .
Discussion
074006
315
7 16:15 16:27 12 min.
Filippo Crea. . Italy
The dilemma of microvascular dysfunction in repeated angina,
an algorithmic plan of management
074007
103
8 16:27 16:30 3 min.
Discussion. .
Discussion
074008
315
9 16:30 16:42 12 min.
Sameh Elamin. NHI. Egypt
Hybrid revascularization, in the armamentarium of coronary
revascularization therapy at 2021?
074009
258
10 16:42 16:45 3 min.
Discussion. .
Discussion
074010
315
11 16:45 16:57 12 min.
Ahmad Mohamed Fathy. NHI. Egypt
Spontaneous coronary artery dissection management
perceptive, case based
074011
30
Page | 22
Prepared by RM Solutions | www.rmsolutions.net
23. PROGRAM BY HALL
Al Hambra 1-2
12 16:57 17:00 3 min.
Discussion. .
Discussion
074012
315
72
8:30
9:30
Al Hambra 1-2
Lipids and Atherosclerosis Session "2" Achieving LDL, the tough
way to go!
Lipids and Atherosclerosis Session
Wed 17-2
*
Chairperson
Hala Gouda
Hamza Kabil
Waleed Abdou
Yasser Elsayed
1 8:30 8:42 12 min.
Alaa Etman. NHI. Egypt
New aggressive targets, should have an evidence?
072001
51
2 8:42 8:45 3 min.
Discussion. .
Discussion
072002
315
3 8:45 8:57 12 min.
Hesham Salah Eldin. Cairo. Egypt
Highest tolerable doses of high intensity statins or
combination of statins with ezetimibe from the start?
072003
337
4 8:57 9:00 3 min.
Discussion. .
Discussion
072004
315
5 9:00 9:12 12 min.
Ihab Attia. Ain Shams. Egypt
PCSK9i …An updated position statement
072005
422
6 9:12 9:15 3 min.
Discussion. .
Discussion
072006
315
7 9:15 9:27 12 min.
Tarek Naguib. Zagazig. Egypt
Statin intolerance, A revisited topic in era of lowest LDL targets
072007
285
8 9:27 9:30 3 min.
Discussion. .
Discussion
072008
315
77
9:30
10:30
Al Hambra 1-2
Best of National Abstract
Medical Track Session
Wed 17-2
*
Page | 23
Prepared by RM Solutions | www.rmsolutions.net
24. PROGRAM BY HALL
Al Hambra 1-2
79
10:30
11:30
Al Hambra 1-2
Primary Prevention Track Session 2: Lessons from Screening in
the General Population. HE. Minister of Health
Primary Prevention Track Session
Wed 17-2
*
Chairperson
Gehan Elassal
Hesham Elhefnawy
Khaled Elhadidi
Mohamed Hassani
Mohamed Mashahet
Mohamed Salah
Sameh Shaheen
1 10:30 10:42 12 min.
Noha Asem. Ministry assistant for research. Egyp
Egypt experience from “100 million healthy Lives initiative”, a
national experience with international lessons
079001
431
2 10:42 10:45 3 min.
Discussion. .
Discussion
079002
315
3 10:45 10:57 12 min.
Randa Abu Elnaga. WHO. Egypt
Opportunistic or mass screening, which is the best to build up
meaningful data? Pros and cons
079003
432
4 10:57 11:00 3 min.
Discussion. .
Discussion
079004
315
5 11:00 11:12 12 min.
Abdellah Abotaleb. NHI. Egypt
Cost Effectiveness of Primary CVD Prevention. A Clear
Message for Low-Middle Income Countries
079005
433
6 11:12 11:15 3 min.
Discussion. .
Discussion
079006
315
7 11:15 11:27 12 min.
Mohamed Hassani. . Egypt
CV complications from antiviral treatment, a national data
from virus C campaign
079007
426
8 11:27 11:30 3 min.
Discussion. .
Discussion
079008
315
Page | 24
Prepared by RM Solutions | www.rmsolutions.net
25. PROGRAM BY HALL
Al Hambra 1-2
78
15:30
16:00
Al Hambra 1-2
Hypertension Track Session "4" Device Therapy: concurring the
Battle
Hypertension Track Session
Wed 17-2
*
Chairperson
Hassan Shehata
Mahmoud Abdelsabour
Mahmoud Ali Soliman
Mousa Akbar
1 15:30 15:42 12 min.
Ahmed Abdullah. . Kuwait
Renal denervation “Is it a true comeback?” A global view on
new data for RDT
078001
21
2 15:42 15:45 3 min.
Discussion. .
Discussion
078002
315
3 15:45 15:57 12 min.
Soliman Ghareeb. Cairo. Egypt
INFRUM device to treat Hypertensive patients
078003
276
4 15:57 16:00 3 min.
Discussion. .
Discussion
078004
315
Page | 25
Prepared by RM Solutions | www.rmsolutions.net
26. PROGRAM BY HALL
Al Hambra 1-2
86
16:00
17:00
Al Hambra 1-2
Joint Session with WHF
Medical Track Session
Wed 17-2
*
Chairperson
Bassem Zarif
Fausto Pinto
Jagat Narula
Karen Sliwa
Khaled Shokry
Magdy Abdelhamid
Mahfouz Elshahawy
Mohamed Ossama
1 16:00 16:12 12 min.
Karen Sliwa. . SAF
Air Pollution and CVD: A Brick Wall or a Window of
Opportunity?
086001
421
2 16:12 16:15 3 min.
Discussion. .
Discussion
086002
315
3 16:15 16:27 12 min.
Jagat Narula. . USA
A professional message from cardiologist to primary care
physician. The core curriculum of NCDs academy
086003
439
4 16:27 16:30 3 min.
Discussion. .
Discussion
086004
315
5 16:30 16:42 12 min.
Bassem Zarif. NHI. Egypt
Comprehensive CVD risk control, an updated manual
086005
85
6 16:42 16:45 3 min.
Discussion. .
Discussion
086006
315
7 16:45 16:57 12 min.
David Wood. . UK
Risk factors control between what should be done and what
happens? Gap in practice!
086007
440
8 16:57 17:00 3 min.
Discussion. .
Discussion
086008
315
Page | 26
Prepared by RM Solutions | www.rmsolutions.net
27. PROGRAM BY HALL
Al Hambra 1-2
87
17:00
18:00
Al Hambra 1-2
Heart Failure Track Session "6" Heart Failure with Preserved
Ejection Fraction: Revision the new data!
Heart Failure Track Session
Wed 17-2
*
Chairperson
Magdy Abdelhamid
Mohamed Abdelghany
Mohamed Gamal
Ragab Abdelsalam
Sherif Wagdy
Tarek Elzawawy
Yasser Kamal
1 17:00 17:15 15 min.
Andrew Coats. . UK
HFpEF: The challenging syndrome, from diagnosis to
management
087001
442
2 17:15 17:20 5 min.
Discussion. .
Discussion
087002
315
3 17:20 17:35 15 min.
Petar Seferovic. . Serbian
Heart failure with recovered EF: Definition, diagnosis and
management
087003
363
4 17:35 17:40 5 min.
Discussion. .
Discussion
087004
315
5 17:40 17:55 15 min.
Hany Ragy. NHI. Egypt
Diagnostic imaging and new therapies of Amyloidosis
087005
128
6 17:55 18:00 5 min.
Discussion. .
Discussion
087006
315
Page | 27
Prepared by RM Solutions | www.rmsolutions.net
28. PROGRAM BY HALL
Al Hambra 1-2
88
8:30
10:00
Al Hambra 1-2
Diabetes and Cardiometabolic syndrome Track Session "3"
Diabetes and CV risk assessment
Diabetes Track Session
Thu 18-2
*
Chairperson
Ahmed Abdel Aziz
Amin Fouad
Khaled Elnady
Lobna Abdel Wahid
Raouf Mahran
Said Farkouh
1 8:30 8:42 12 min.
Sameh Bakhom. Cairo. Egypt
Do all diabetics have same CVD risk?
088001
367
2 8:42 8:45 3 min.
Discussion. .
Discussion
088002
315
3 8:45 8:57 12 min.
Mahfouz Elshahawy. . USA
My strategy of management in Diabetics in primary and
secondary CVD prevention?
088003
378
4 8:57 9:00 3 min.
Discussion. .
Discussion
088004
315
5 9:00 9:12 12 min.
Fausto Pinto. . Portugal
Diabetics with heart failure, do they need a special care?
088005
438
6 9:12 9:15 3 min.
Discussion. .
Discussion
088006
315
7 9:15 9:27 12 min.
Ehab El Hefny. Azhar. Egypt
Diabetics CV care in coronary artery disease
088007
345
8 9:27 9:30 3 min.
Discussion. .
Discussion
088008
315
9 9:30 9:42 12 min.
Khaled Elnady. Military. Egypt
Diabetics with AF, do they need a special care?
088009
164
10 9:42 9:45 3 min.
Discussion. .
Discussion
088010
315
11 9:45 9:57 12 min.
Seif Kamal Abou Seif. MOH. Egypt
Screening and CV risk scoring for prediabetes when, how and
whom?
088011
376
Page | 28
Prepared by RM Solutions | www.rmsolutions.net
29. PROGRAM BY HALL
Al Hambra 1-2
12 9:57 10:00 3 min.
Discussion. .
Discussion
088012
315
Page | 29
Prepared by RM Solutions | www.rmsolutions.net
30. PROGRAM BY HALL
Al Hambra 1-2
89
10:00
11:30
Al Hambra 1-2
Heart failure Track Session "4" Acute Heart Failure in 2021
Heart Failure Track Session
Thu 18-2
*
Chairperson
Ahmed Abdel-Galeel
Ihab Daoud Hanna
Magdy Abdelhamid
Maged Al Abbady
Medhat Elsayed
Mohamed Sobhy
Sameh Emil
1 10:00 10:15 15 min.
Bassem Sobhy. . UK
The art to assess congestion in AHF
089001
446
2 10:15 10:20 5 min.
Discussion. .
Discussion
089002
315
3 10:20 10:35 15 min.
Feras Bader. . UAE
“Pharmacological treatment” from ER up to discharge, An
update
089003
447
4 10:35 10:40 5 min.
Discussion. .
Discussion
089004
315
5 10:40 10:55 15 min.
Guisepe Rosano. . UK
“Non-Pharmacological treatment”, Does it work in AHF?
089005
420
6 10:55 11:00 5 min.
Discussion. .
Discussion
089006
315
7 11:00 11:12 12 min.
Hussien Elfishawy. . Egypt
Cardio-renal challenges in management of AHF! Nephrology
View
089007
448
8 11:12 11:15 3 min.
Discussion. .
Discussion
089008
315
9 11:15 11:27 12 min.
Mahmoud Hassanin. Alexandria. Egypt
Cardio-renal challenges in management of AHF! Cardiology
View
089009
449
10 11:27 11:30 3 min.
Discussion. .
Discussion
089010
315
Page | 30
Prepared by RM Solutions | www.rmsolutions.net
31. PROGRAM BY HALL
Al Hambra 1-2
96
15:30
17:00
Al Hambra 1-2
Heart failure Track| Session 5: Heart Failure with Reduced
Ejection Fraction
Heart Failure Track Session
Thu 18-2
*
Chairperson
Emanuele Louka
Khaled Eltohamy
Mahmoud Hassanin
Mohamed Gamal
Nasser Taha
1 15:30 15:55 25 min.
Andrew Coats. . UK
State of the art lecture: Current and future therapy of HFrEF
096001
442
2 15:55 16:00 5 min.
Discussion. .
Discussion
096002
315
3 16:00 16:12 12 min.
Mohamed Hassan. Cairo. Egypt
Debate: Treatment of secondary mitral regurge:
percutaneously or surgical; Could it help? Yes it helps
096003
204
4 16:12 16:15 3 min.
Discussion. .
Discussion
096004
315
5 16:15 16:27 12 min.
Mohamed Seleem. NHI. Egypt
Debate: Treatment of secondary mitral regurge:
percutaneously or surgical; Could it help? No it won't
096005
215
6 16:27 16:30 3 min.
Discussion. .
Discussion
096006
315
7 16:30 16:50 20 min.
Feras Bader. . UAE
Device therapy in HF, in 2021
096007
447
8 16:50 17:00 10 min.
Discussion. .
Discussion
096008
315
Page | 31
Prepared by RM Solutions | www.rmsolutions.net
32. PROGRAM BY HALL
Al Hambra 1-2
97
17:00
18:00
Al Hambra 1-2
Heart failure Track| Session 8: Patient Journey in Heart Failure
Heart Failure Track Session
Thu 18-2
*
Chairperson
Diaa Dardir
Ghada Sayed Youssef
Mohamed Zaki
Ossama Sanad
Soha Romeih
Tarek Abo Elazm
1 17:00 17:12 12 min.
Ahmed Bendary. Benha. Egypt
A story teller spotting the natural history of the disease.
097001
25
2 17:12 17:15 3 min.
Discussion. .
Discussion
097002
315
3 17:15 17:27 12 min.
Bassem Zarif. NHI. Egypt
Precious steps to act (prevent/stop HF) between what should
be done and what happens?
097003
85
4 17:27 17:30 3 min.
Discussion. .
Discussion
097004
315
5 17:30 17:42 12 min.
Walid Ammar. Cairo. Egypt
HF terminal care
097005
301
6 17:42 17:45 3 min.
Discussion. .
Discussion
097006
315
7 17:45 17:57 12 min.
Yasmine Aguib. AHC. Egypt
The horizon of genetic therapy
097007
413
8 17:57 18:00 3 min.
Discussion. .
Discussion
097008
315
Page | 32
Prepared by RM Solutions | www.rmsolutions.net
33. PROGRAM BY HALL
Al Hambra 2
202
14:00
15:00
Al Hambra 2
Valvular Management Updates 1
Medical Track Session
Mon 15-2
*
Chairperson
Hossam El Masry
Khalid El Rabbat
1 14:00 14:15 15 min.
Osama Refaei. Ain Shams. Egypt
On going inflammatory state in chronic rheumatic heart
disease
202001
767
2 14:15 14:20 5 min.
Discussion. .
Discussion
202002
315
3 14:20 14:35 15 min.
Fathy Maklady. Suez Canal. Egypt
2020 guidelines, what’s new?
202003
816
4 14:35 14:40 5 min.
Discussion. .
Discussion
202004
315
5 14:40 14:55 15 min.
Alaa El Ghamrawy. Mahala. Egypt
TBA
202005
738
6 14:55 15:00 5 min.
Discussion. .
Discussion
202006
315
Page | 33
Prepared by RM Solutions | www.rmsolutions.net
34. PROGRAM BY HALL
Al Hambra 2
60
15:00
15:30
Al Hambra 2
Primary Prevention Track Session "1" Risk Scoring Debate
Preventive cardiology Track Session
Mon 15-2
*
Chairperson
Hala Gouda
1 15:00 15:12 12 min.
Mahfouz Elshahawy. . USA
Pro; Scoring Systems Accurately Estimate CVD Risk in Primary
Prevention and should be Applied to Everyone
060001
378
2 15:12 15:15 3 min.
Discussion. .
Discussion
060002
315
3 15:15 15:27 12 min.
Ramez Sam. . Egypt
Contra; Scoring systems is underestimating risk in primary
prevention, and shouldn’t be the only way to assess CVD risk in
this group
060003
379
4 15:27 15:30 3 min.
Discussion. .
Discussion
060004
315
Page | 34
Prepared by RM Solutions | www.rmsolutions.net
35. PROGRAM BY HALL
Al Hambra 2
62
15:30
16:30
Al Hambra 2
Primary Prevention Track Session "4" Lifestyle Modifications
Primary Prevention Track Session
Mon 15-2
*
Chairperson
Kamal Mahmoud
Khaled Elnady
Lobna Abdel Wahid
Mohamed Elbahy
1 15:30 15:42 12 min.
Gihan Fouad. . Egypt
Diet Control for CVD Prevention, what cardiologists should
know?
062001
114
2 15:42 15:45 3 min.
Discussion. .
Discussion
062002
315
3 15:45 15:57 12 min.
Sherif Azmy. . Egypt
Meat processed, unprocessed and its correlation to CVD risk
062003
743
4 15:57 16:00 3 min.
Discussion. .
Discussion
062004
315
5 16:00 16:12 12 min.
Sameh Thabet. . Egypt
Merits of exercise for CV protection
062005
745
6 16:12 16:15 3 min.
Discussion. .
Discussion
062006
315
7 16:15 16:27 12 min.
Mohamed Eid Morsy. Sohag. Egypt
Intermittent fasting and cardiovascular health
062007
812
8 16:27 16:30 3 min.
Discussion. .
Discussion
062008
315
Page | 35
Prepared by RM Solutions | www.rmsolutions.net
36. PROGRAM BY HALL
Al Hambra 2
64
16:30
17:30
Al Hambra 2
Pulmonary Hypertension and VTE Session "1"
Pulmonary Hypertension and VTE Trac Session
Mon 15-2
*
Chairperson
Gehan Elassal
Hossam Masoud
Reem Elkorashy
1 16:30 16:42 12 min.
Ayman khairy. Assiut. Egypt
Pitfalls in management of pulmonary hypertension
064001
397
2 16:42 16:45 3 min.
Discussion. .
Discussion
064002
315
3 16:45 16:57 12 min.
Ahmed Abdel Aziz. NHI. Egypt
Group II pulmonary hypertension not all in one basket
064003
348
4 16:57 17:00 3 min.
Discussion. .
Discussion
064004
315
5 17:00 17:12 12 min.
Youssef Amin. Cairo. Egypt
Insights from Egyptian registry of PH
064005
398
6 17:12 17:15 3 min.
Discussion. .
Discussion
064006
315
7 17:15 17:27 12 min.
Sally Magdy. Cairo. Egypt
Case presentation
064007
399
8 17:27 17:30 3 min.
Discussion. .
Discussion
064008
315
Page | 36
Prepared by RM Solutions | www.rmsolutions.net
37. PROGRAM BY HALL
Al Hambra 2
70
12:30
13:30
Al Hambra 2
Hypertension Track: Meet The Experts from Hypertension to
Intervention
Hypertension Track Session
Tue 16-2
*
Chairperson
Mohaned Egred
Tarek Zaki
1 12:30 12:50 20 min.
Anastasia Mihailidou. . Australia
Hypertension Guidelines, Gap in evidence
070001
842
2 12:50 13:00 10 min.
Discussion. .
Discussion
070002
315
3 13:00 13:20 20 min.
Mamas Mamas. . UK
LM stening
070003
501
4 13:20 13:30 10 min.
Discussion. .
Discussion
070004
315
Page | 37
Prepared by RM Solutions | www.rmsolutions.net
38. PROGRAM BY HALL
Al Hambra 2
73
14:30
15:30
Al Hambra 2
Primary Prevention Track Session "3" Expanding the role of
precision medicine in cardiology; from lifestyle management to
genetic therapy
Primary Prevention Track Session
Tue 16-2
*
Chairperson
Ayman Saleh
Mohamed Farid El-Guindy
1 14:30 14:45 15 min.
Ahmed Elguindy. AHC. Egypt
Imaging for Risk Assessment, what Cardiologist should know?
073001
27
2 14:45 14:50 5 min.
Discussion. .
Discussion
073002
315
3 14:50 15:05 15 min.
Martha Gulati. . Canada
Prevention ABCD&E
073003
412
4 15:05 15:10 5 min.
Discussion. .
Discussion
073004
315
5 15:10 15:25 15 min.
Yasmine Aguib. AHC. Egypt
Genetic percepctives in CVD prevention
073005
413
6 15:25 15:30 5 min.
Discussion. .
Discussion
073006
315
Page | 38
Prepared by RM Solutions | www.rmsolutions.net
39. PROGRAM BY HALL
Al Hambra 2
76
17:00
18:00
Al Hambra 2
Heart Failure Track Session "7" HF Miscellaneous hot topics
Heart Failure Track Session
Tue 16-2
*
Chairperson
Khaled Elkhashab
Khaled Elmaghraby
Khalid El Rabbat
Magdy Abdelhamid
Maged Ramses
Mansour Atef
1 17:00 17:15 15 min.
Guisepe Rosano. . UK
Diagnosis and treatment of myocarditis in 2021
076001
420
2 17:15 17:20 5 min.
Discussion. .
Discussion
076002
315
3 17:20 17:35 15 min.
Karen Sliwa. . SAF
Peripartum cardiomyopathy: New data by the Expert
076003
421
4 17:35 17:40 5 min.
Discussion. .
Discussion
076004
315
5 17:40 17:55 15 min.
Karim Said. Cairo. Egypt
RV: The forgotten chamber in heart failure?
076005
332
6 17:55 18:00 5 min.
Discussion. .
Discussion
076006
315
Page | 39
Prepared by RM Solutions | www.rmsolutions.net
40. PROGRAM BY HALL
Al Hambra 2
82
12:30
13:30
Al Hambra 2
Joint Session with International Delegate Session
Medical Track Session
Wed 17-2
*
Chairperson
Bassem Zarif
Haseeb Raza
Yasmin Rustamova
1 12:30 12:38 8 min.
Sara Moscatelli. . UK
Women in Cardiology: from cardiovascular diseases in women
to gender equality
082001
727
2 12:38 12:42 4 min.
Discussion. .
Discussion
082002
315
3 12:42 12:50 8 min.
Arash Hashemi. . Iran
Complications in a very complex CTO case
082003
728
4 12:50 12:54 4 min.
Discussion. .
Discussion
082004
315
5 12:54 13:02 8 min.
Assad Samy. NHI. Egypt
PCI Lesson
082005
750
6 13:02 13:06 4 min.
Discussion. .
Discussion
082006
315
7 13:06 13:14 8 min.
Irina Kotlar Velkova. . Macedonia
Covid-related thrombo-embolism in depth
082007
729
8 13:14 13:18 4 min.
Discussion. .
Discussion
082008
315
9 13:18 13:26 8 min.
Fady Gerges. . UAE
How to perform a proper Saline Contrast Echo (SCE) study
082009
730
10 13:26 13:30 4 min.
Discussion. .
Discussion
082010
315
Page | 40
Prepared by RM Solutions | www.rmsolutions.net
41. PROGRAM BY HALL
Al Hambra 2
85
14:30
15:30
Al Hambra 2
Primary Prevention Track Session "5" The Hidden CV Risk
Primary Prevention Track Session
Wed 17-2
*
Chairperson
Gamal Aboul Nasr
Khaled Said Osman
Omar Elbahi
Tarek Zaki
1 14:30 14:42 12 min.
Omar Khashab. Cairo. Egypt
Uric acid and CVD risk, A position statement
085001
435
2 14:42 14:45 3 min.
Discussion. .
Discussion
085002
315
3 14:45 14:57 12 min.
Maged Tawfik. . Egypt
Autoimmune diseases and CVD risk, how to evaluate individual
patient risk?
085003
436
4 14:57 15:00 3 min.
Discussion. .
Discussion
085004
315
5 15:00 15:12 12 min.
Walaa Adel. Ain Shams. Egypt
Back to basic definitions in CVD prevention, what’s risk
marker, risk factor, risk enhancers
085005
299
6 15:12 15:15 3 min.
Discussion. .
Discussion
085006
315
7 15:15 15:27 12 min.
Ahmed Wafa. Mansoura. Egypt
Beginning of estrogen soon after menopause and CVD
prevention, the big question?
085007
49
8 15:27 15:30 3 min.
Discussion. .
Discussion
085008
315
Page | 41
Prepared by RM Solutions | www.rmsolutions.net
42. PROGRAM BY HALL
Al Hambra 2
92
12:30
13:30
Al Hambra 2
Innovation 2 Session "1" The cardiac innovation in different
cardiac fields in the last decade
Innovation Track Session
Thu 18-2
*
1 12:30 12:45 15 min.
Sameh Elamin. NHI. Egypt
The most recent Innovation in different cardiac surgical
techniques in the last decade (3D bio-printed heart tissue)
092001
258
2 12:45 12:50 5 min.
Discussion. .
Discussion
092002
315
3 12:50 13:05 15 min.
Amr Zaher. NHI. Egypt
The Novel power therapy in medicin (the magnet and laser
therapy and others)???
092003
66
4 13:05 13:10 5 min.
Discussion. .
Discussion
092004
315
5 13:10 13:25 15 min.
Mohamed Helmy. NHI. Egypt
The debate around the non-conventional drug therapy (herbal,
cup therapy, the acupuncture in the cardiac field)
092005
205
6 13:25 13:30 5 min.
Discussion. .
Discussion
092006
315
Page | 42
Prepared by RM Solutions | www.rmsolutions.net
43. PROGRAM BY HALL
Al Hambra 2
95
14:30
15:30
Al Hambra 2
Innovation 2 Session "2" The cardiac innovation in different
cardiac fields in the last decade
Innovation Track Session
Thu 18-2
*
1 14:30 14:45 15 min.
Rabeay Younes Hassan. Zewail University. Egypt
Treatment and prevention of biofilm formation on a complex-
shaped metallic implants
095001
867
2 14:45 14:50 5 min.
Discussion. .
Discussion
095002
315
3 14:50 15:05 15 min.
TBA. .
Debate in cell therapy in cardiology
095003
316
4 15:05 15:10 5 min.
Discussion. .
Discussion
095004
315
5 15:10 15:25 15 min.
Ahmed Abdullah. . Kuwait
The noval Robot therapy in the cardiology field (intervention
and surgical fields)
095005
21
6 15:25 15:30 5 min.
Discussion. .
Discussion
095006
315
Page | 43
Prepared by RM Solutions | www.rmsolutions.net
44. PROGRAM BY HALL
Al Manial
167
9:00
11:00
Al Manial
Innovation 1 the cardiac innovation in different cardiac fields in
the last decade
Medical Track Session
Mon 15-2
*
1 9:00 9:15 15 min.
Mohamed Helmy. NHI. Egypt
Introduction for cardiac innovations
167001
205
2 9:15 9:20 5 min.
Discussion. .
Discussion
167002
315
3 9:20 9:35 15 min.
Sameh Shaheen. Ain Shams. Egypt
Innovations in the interventional cardiology materials,
machines, and techniques in the last 10 years
167003
261
4 9:35 9:40 5 min.
Discussion. .
Discussion
167004
315
5 9:40 9:55 15 min.
Ahmed M. Onsy. Ain Shams. Egypt
Innovations in noninvasive cardiology in the last decade
167005
40
6 9:55 10:00 5 min.
Discussion. .
Discussion
167006
315
7 10:00 10:15 15 min.
Khaled Leon. NHI. Egypt
How to document your idea in the legal way??
167007
166
8 10:15 10:20 5 min.
Discussion. .
Discussion
167008
315
9 10:20 10:35 15 min.
Ihab Daoud Hanna. Italian Hospital. Egypt
The new Innovation in the field of heart failure in the last
decade
167009
151
10 10:35 10:40 5 min.
Discussion. .
Discussion
167010
315
11 10:40 10:55 15 min.
Ossama Abd El Raouf. . Egypt
The most recent Innovations in cardiac drug therapy in the last
10 years
167011
238
12 10:55 11:00 5 min.
Discussion. .
Discussion
167012
315
Page | 44
Prepared by RM Solutions | www.rmsolutions.net
45. PROGRAM BY HALL
Al Manial
168
11:00
12:00
Al Manial
Cardiac Rehabilitation 1: Should I participate in a cardiac rehab
program?
Medical Track Session
Mon 15-2
*
1 11:00 11:15 15 min.
Wael El kilany. Ain Shams. Egypt
Back to Normal life after M1, what the physician should know?
Risk stratification for Physical instructions
168001
297
2 11:15 11:30 15 min.
Adel Shabana. . Egypt
Back to Normal life after M1, what the physician should know?
General and specific Mental, moral and social support
168002
14
3 11:30 11:45 15 min.
Hazem Khorshid. Ain Shams. Egypt
Exercise prescription in CR incorporating what is new in ESC
guidelines
168003
136
4 11:45 12:00 15 min.
Mahmoud El Habiby. . Egypt
Psychiatric Aspects of Cardiac Rehabilitation in Covid-19
Pandemic
168004
182
Page | 45
Prepared by RM Solutions | www.rmsolutions.net
46. PROGRAM BY HALL
Al Manial
169
12:00
13:00
Al Manial
Pericardium (The missed puzzle piece)
Medical Track Session
Mon 15-2
*
Chairperson
Aziz Madkour
Mansour Atef
Samia Elkady
1 12:00 12:12 12 min.
TBA. .
Diagnosing Pericardial Diseases. Can the Multimodality
Imaging Guide Therapy?
169001
316
2 12:12 12:15 3 min.
Discussion. .
Discussion
169002
315
3 12:15 12:27 12 min.
Hesham Nasr. NHI. Egypt
Pericardial disease, updated treatment options
169003
323
4 12:27 12:30 3 min.
Discussion. .
Discussion
169004
315
5 12:30 12:42 12 min.
Tamer Elashkar. NHI. Egypt
Large Pericardial Effusion; when to drain or refrain??
169005
359
6 12:42 12:45 3 min.
Discussion. .
Discussion
169006
315
7 12:45 12:57 12 min.
Haytham Soliman. Fayoum. Egypt
The real pain for the Cardiologist; Chronic Idiopathic
Pericarditis, any remedy?
169007
134
8 12:57 13:00 3 min.
Discussion. .
Discussion
169008
315
170
13:00
14:00
Al Manial
Bayer Workshop
Medical Track Workshop
Mon 15-2
*
Page | 46
Prepared by RM Solutions | www.rmsolutions.net
47. PROGRAM BY HALL
Al Manial
171
14:00
15:00
Al Manial
Cardio-Oncology: The Expanding Horizon
Medical Track Session
Mon 15-2
*
Chairperson
Ahmad Mohamed Fathy
Amr Ahmed Youssef
Hossam Kandil
Ibtsam Khairat Ibrahim
Walaa Farid
1 14:00 14:15 15 min.
Hamza Kabil. Damietta. Egypt
Incidence of events between vitamin K antagonists and direct
oral anticoagulants in patients with cancer
171001
121
2 14:15 14:20 5 min.
Discussion. .
Discussion
171002
315
3 14:20 14:35 15 min.
Ramadan Ghaleb. Aswan. Egypt
The Impact of a multi-disciplinary cardio-oncology program on
the cardiovascular outcomes in breast cancer patients
171003
619
4 14:35 14:40 5 min.
Discussion. .
Discussion
171004
315
5 14:40 14:55 15 min.
Hussien Rizk. Cairo. Egypt
The Need for Precision in Cardio-Oncology; Cardiac aspects of
targeted cancer therapy
171005
620
6 14:55 15:00 5 min.
Discussion. .
Discussion
171006
315
Page | 47
Prepared by RM Solutions | www.rmsolutions.net
48. PROGRAM BY HALL
Al Manial
172
15:00
16:00
Al Manial
Sport Cardiology
Medical Track Session
Mon 15-2
*
Chairperson
Mohamed El Maghawry
Mohammad Eltahlawi
Tarek Aziz
Yasser Hosny
1 15:00 15:12 12 min.
Hany El Shahidy. NHI. Egypt
Sport Cardiology and Sudden cardiac death in athletes, the
unresolved issues
172001
488
2 15:12 15:15 3 min.
Discussion. .
Discussion
172002
315
3 15:15 15:27 12 min.
Hazem Khamis. Military. Egypt
Pre-participation cardiac assessment
172003
135
4 15:27 15:30 3 min.
Discussion. .
Discussion
172004
315
5 15:30 15:42 12 min.
Gamela Nasr. Suez Canal. Egypt
Echocardiography of athletic heart
172005
110
6 15:42 15:45 3 min.
Discussion. .
Discussion
172006
315
7 15:45 15:57 12 min.
Ahmed Ashraf Eissa. Ain Shams. Egypt
ESC sport Cardiology guidelines, What’s new?
172007
23
8 15:57 16:00 3 min.
Discussion. .
Discussion
172008
315
Page | 48
Prepared by RM Solutions | www.rmsolutions.net
49. PROGRAM BY HALL
Al Manial
173
16:00
17:00
Al Manial
Communication skills: Empower your business and help patients
to achieve targets…Effective communication with your patients
Medical Track Session
Mon 15-2
*
Chairperson
Bassem Zarif
Fakher Elaouby
Maged Naeem
Nabil Kitchener
Osama Louis
1 16:00 17:00 60 min.
Rafaat Yousef. . Egypt
Topic 1 Verbal communications
173001
629
Topic 2 Non-verbal communications
Topic 3 Effective negotiation with patients
Topic 4 How to deal with different and difficult types of patient
2 16:00 17:00 60 min.
Shereen Metwally. . Egypt
Topic 1 Verbal communications
173002
630
Topic 2 Non-verbal communications
Topic 3 Effective negotiation with patients
Topic 4 How to deal with different and difficult types of patient
203
17:00
18:00
Al Manial
Valvular Management Updates 2
Medical Track Session
Mon 15-2
*
1 17:00 17:20 20 min.
Marwa Mashaal. Kasr El Ainy. Egypt
IE national experience
203001
740
2 17:20 17:30 10 min.
Discussion. .
Discussion
203002
315
3 17:30 17:50 20 min.
TBA. .
Rheumatic heart disease, updated echo diagnosis in daily
practice
203003
316
4 17:50 18:00 10 min.
Discussion. .
Discussion
203004
315
Page | 49
Prepared by RM Solutions | www.rmsolutions.net
50. PROGRAM BY HALL
Al Manial
174
9:00
10:00
Al Manial
Cardiac Rehabilitation 2: Clinical Nutrition in Cardiac Rehab:
Special Concerns
Medical Track Session
Tue 16-2
*
1 9:00 9:15 15 min.
Ahmed Farghaly. NHI. Egypt
Nutritional assessment and Nutritional protocols for post-
operative cardiac surgery patient)
174001
748
2 9:15 9:30 15 min.
Gihan Fouad. . Egypt
Nutritional Intervention in Cardiac patient. Which diet should
you choose?
174002
114
3 9:30 9:45 15 min.
Atef Elsayed Fayed. . Egypt
Factors affecting clinical nutrition in the intensive care unit,
especially during the Covid-19 pandemic
174003
73
4 9:45 10:00 15 min.
Bassem Boulos. . Egypt
Nutrition for mechanically ventilated patients
174004
84
Page | 50
Prepared by RM Solutions | www.rmsolutions.net
51. PROGRAM BY HALL
Al Manial
175
10:00
11:30
Al Manial
Joint Session with Saudi Cardiac Clinical Pharmacists. Clinical
Pharmacy: Potential Role in Modern Cardiology
Medical Track Session
Tue 16-2
*
Chairperson
Bassem Zarif
Hatem Elsokkary
1 10:00 10:12 12 min.
TBA. .
COVID-19 treatment in CVD, precautions and possible
interactions
175001
316
2 10:12 10:15 3 min.
Discussion. .
Discussion
175002
315
3 10:15 10:27 12 min.
Fakher Elaouby. . KSA
Role of clinical pharmacist In HF clinics
175003
628
4 10:27 10:30 3 min.
Discussion. .
Discussion
175004
315
5 10:30 10:42 12 min.
TBA. .
Integrated CVD care, a horizon for true multidisciplinary
approach, what clinical pharmacist could do?
175005
316
6 10:42 10:45 3 min.
Discussion. .
Discussion
175006
315
7 10:45 10:57 12 min.
Naglaa Bazan. Cairo. Egypt
Anti-thrombotic therapy in COVID-19
175007
860
8 10:57 11:00 3 min.
Discussion. .
Discussion
175008
315
9 11:00 11:12 12 min.
TBA. .
Recent updates in pharmacological management of
dyslipidemia
175009
316
10 11:12 11:15 3 min.
Discussion. .
Discussion
175010
315
11 11:15 11:27 12 min.
TBA. .
Updates in cardiovascular medicine, clinical pharmacist
percepective
175011
316
12 11:27 11:30 3 min.
Discussion. .
Discussion
175012
315
Page | 51
Prepared by RM Solutions | www.rmsolutions.net
52. PROGRAM BY HALL
Al Manial
176
12:30
13:30
Al Manial
Bayer Workshop
Medical Track Workshop
Tue 16-2
*
177
14:30
15:30
Al Manial
Diagnosing Perioperative Cardiovascular Risks in Non-Cardiac
Surgery Patients
Medical Track Session
Tue 16-2
*
Chairperson
Mohamed Elgabaly
Nawal Shawky
Sameh Samir
1 14:30 14:42 12 min.
Hisham Selim. NHI. Egypt
Precautions and Recommendations for CV Patients and
Laparoscopic General Surgery. Anesthesiologist perspective
177001
492
2 14:42 14:45 3 min.
Discussion. .
Discussion
177002
315
3 14:45 14:57 12 min.
Sayed Abdou. . KSA
Functional vs Structural Assessment, which is better, to stratify
your patient?
177003
267
4 14:57 15:00 3 min.
Discussion. .
Discussion
177004
315
5 15:00 15:12 12 min.
Mahmoud Tantawy. . Egypt
Any Role for Biomarkers before General Surgery of Cardiac
Patients??
177005
633
6 15:12 15:15 3 min.
Discussion. .
Discussion
177006
315
7 15:15 15:27 12 min.
Abdelrahman Elbokary. NHI. Egypt
The Tough Decision for the Cardiologist; PCI before Non-
cardiac Surgery. What are the options??
177007
5
8 15:27 15:30 3 min.
Discussion. .
Discussion
177008
315
Page | 52
Prepared by RM Solutions | www.rmsolutions.net
53. PROGRAM BY HALL
Al Manial
178
15:30
16:30
Al Manial
Women in cardiology
Medical Track Session
Tue 16-2
*
Chairperson
Ikram Sadek
Kawkab Khedr
Naglaa Mokhtar
Sahar Hamdy
Taghreed Helal
Walaa Farid
1 15:30 15:42 12 min.
Martha Gulati. . Canada
Women and heart disease: Is there really a sex difference?
178001
412
2 15:42 15:45 3 min.
Discussion. .
Discussion
178002
315
3 15:45 15:57 12 min.
Mahmoud Ali Soliman. Menofia. Egypt
Pregnancy when to advice against and when to terminate,
with focus on how to investigate?
178003
423
4 15:57 16:00 3 min.
Discussion. .
Discussion
178004
315
5 16:00 16:12 12 min.
Nasser Taha. Minia. Egypt
Pregnancy and heart disease: an Egyptian perceptive
178005
230
6 16:12 16:15 3 min.
Discussion. .
Discussion
178006
315
7 16:15 16:27 12 min.
Hany El Shahidy. NHI. Egypt
American Heart Association Program (Go Red for Women in
Egypt)
178007
488
8 16:27 16:30 3 min.
Discussion. .
Discussion
178008
315
Page | 53
Prepared by RM Solutions | www.rmsolutions.net
54. PROGRAM BY HALL
Al Manial
179
16:30
17:30
Al Manial
Best of National Cases Revise with the experts “1”
Medical Track Session
Tue 16-2
*
Chairperson
Ahmed Kamel
Antonious Attallah
Azeem Latib
Mamas Mamas
Osama Shoeib
1 16:30 16:38 8 min.
TBA. .
Case 1
179001
316
2 16:38 16:42 4 min.
Discussion. .
Discussion
179002
315
3 16:42 16:50 8 min.
TBA. .
Case 2
179003
316
4 16:50 16:54 4 min.
Discussion. .
Discussion
179004
315
5 16:54 17:02 8 min.
TBA. .
Case 3
179005
316
6 17:02 17:06 4 min.
Discussion. .
Discussion
179006
315
7 17:06 17:14 8 min.
TBA. .
Case 4
179007
316
8 17:14 17:18 4 min.
Discussion. .
Discussion
179008
315
9 17:18 17:26 8 min.
TBA. .
Case 5
179009
316
10 17:26 17:30 4 min.
Discussion. .
Discussion
179010
315
Page | 54
Prepared by RM Solutions | www.rmsolutions.net
55. PROGRAM BY HALL
Al Manial
180
9:00
10:00
Al Manial
Cardiac Rehabilitation 3: Cardiac Rehabilitation in Certain Clinical
Conditions
Medical Track Session
Wed 17-2
*
Chairperson
Tarek Aziz
1 9:00 9:15 15 min.
Walaa Adel. Ain Shams. Egypt
Cardio-oncology rehabilitation for cancer patients and
survivors
180001
299
2 9:15 9:30 15 min.
Osama Louis. NHI. Egypt
Cardiac Rehabilitation in heart failure patients in Covid-19 era:
home based management during lockdown
180002
239
3 9:30 9:45 15 min.
Ahmad Kadry. . Egypt
Cardiac Rehab in elderly heart failure patient
180003
17
4 9:45 10:00 15 min.
Yasser Alaa. . Egypt
Cardiac Telerehabilitation in the era of Covid-19 pandemic
180004
305
Page | 55
Prepared by RM Solutions | www.rmsolutions.net
56. PROGRAM BY HALL
Al Manial
181
10:00
11:00
Al Manial
Pulmonary Hypertension and VTE Session 2
Pulmonary Hypertension and VTE Trac Session
Wed 17-2
*
Chairperson
Ali Mahmoud Kassem
Omar Elbahi
1 10:00 10:12 12 min.
Wael Soliman. Alexandria. Egypt
CTEPH beyond the standard management
181001
641
2 10:12 10:15 3 min.
Discussion. .
Discussion
181002
315
3 10:15 10:27 12 min.
Medhat Abdel khalek. Cairo. Egypt
PAH in ICU
181003
642
4 10:27 10:30 3 min.
Discussion. .
Discussion
181004
315
5 10:30 10:42 12 min.
Youssef Amin. Cairo. Egypt
Pulmonary hypertension in pregnancy
181005
398
6 10:42 10:45 3 min.
Discussion. .
Discussion
181006
315
7 10:45 10:57 12 min.
Michael Nagy. AHC. Egypt
Case presentation
181007
643
8 10:57 11:00 3 min.
Discussion. .
Discussion
181008
315
182
12:30
13:30
Al Manial
Bayer Workshop
Medical Track Workshop
Wed 17-2
*
Page | 56
Prepared by RM Solutions | www.rmsolutions.net
57. PROGRAM BY HALL
Al Manial
183
14:30
16:00
Al Manial
Joint Session with ISCVDP
Medical Track Session
Wed 17-2
*
Chairperson
Bassem Zarif
Fausto Pinto
Gamela Nasr
Khaled Elnady
Mahfouz Elshahawy
1 14:30 14:45 15 min.
Nanette Wenger. . USA
Woman's heart disease
183001
733
2 14:45 14:50 5 min.
Discussion. .
Discussion
183002
315
3 14:50 15:05 15 min.
Ann Curtis. . USA
Atrial Fibrillation current guidelines
183003
734
4 15:05 15:10 5 min.
Discussion. .
Discussion
183004
315
5 15:10 15:25 15 min.
Elizabeth Ofili. . USA
Cardio metabolic syndrom
183005
735
6 15:25 15:30 5 min.
Discussion. .
Discussion
183006
315
7 15:30 15:45 15 min.
Jay Cohn. . USA
Novel approach for cardiovascular disease early detection
183007
736
8 15:45 15:50 5 min.
Discussion. .
Discussion
183008
315
9 15:50 16:00 10 min.
Discussion. .
General discussion between speakers and attendees
183009
315
Page | 57
Prepared by RM Solutions | www.rmsolutions.net
58. PROGRAM BY HALL
Al Manial
184
16:00
17:00
Al Manial
Best of National Cases Revise with the experts “2”
Medical Track Session
Wed 17-2
*
Chairperson
Ayman Aboul Magd
Francesco Burzotta
Mirvat Al Asnag
1 16:00 16:08 8 min.
TBA. .
Case 1
184001
316
2 16:08 16:12 4 min.
Discussion. .
Discussion
184002
315
3 16:12 16:20 8 min.
TBA. .
Case 2
184003
316
4 16:20 16:24 4 min.
Discussion. .
Discussion
184004
315
5 16:24 16:32 8 min.
TBA. .
Case 3
184005
316
6 16:32 16:36 4 min.
Discussion. .
Discussion
184006
315
7 16:36 16:44 8 min.
TBA. .
Case 4
184007
316
8 16:44 16:48 4 min.
Discussion. .
Discussion
184008
315
9 16:48 16:56 8 min.
TBA. .
Case 5
184009
316
10 16:56 17:00 4 min.
Discussion. .
Discussion
184010
315
Page | 58
Prepared by RM Solutions | www.rmsolutions.net
59. PROGRAM BY HALL
Al Manial
185
17:00
18:00
Al Manial
Joint Session with ESC Heart and Stoke
Medical Track Session
Wed 17-2
*
Chairperson
Bassem Zarif
Wolfram Doehner
1 17:00 17:12 12 min.
Renate Schnabel. .
Detection of atrial fibrillation after embolic stroke: diagnostic
strategies
185001
845
2 17:12 17:15 3 min.
Discussion. .
Discussion
185002
315
3 17:15 17:27 12 min.
Jan Kovac. .
Training requirements for mechanical thrombectomy in acute
stroke – a European perspective
185003
846
4 17:27 17:30 3 min.
Discussion. .
Discussion
185004
315
5 17:30 17:42 12 min.
Wolfram Doehner. .
The role of the Cardiologist on a stroke unit
185005
847
6 17:42 17:45 3 min.
Discussion. .
Discussion
185006
315
7 17:45 17:57 12 min.
TBA. .
TBA
185007
316
8 17:57 18:00 3 min.
Discussion. .
Discussion
185008
315
Page | 59
Prepared by RM Solutions | www.rmsolutions.net
60. PROGRAM BY HALL
Al Manial
186
8:30
10:30
Al Manial
Nursing & Tech. (1)
Nurs/ Tech Track Session
Thu 18-2
*
Chairperson
Afrah Mohamed Abdel Fattah
Ahmed Abdel Mawla
Ghazaly Amer
Tarek Hosny
1 8:30 8:50 20 min.
Aya El Sheikh. Louran Hospital. Egypt
Patient safety in cath.Lab
186001
75
2 8:50 8:54 4 min.
Discussion. .
Discussion
186002
315
3 8:54 9:14 20 min.
Amr Abd Rabou. Cairo. Egypt
Administarative cardiology
186003
61
4 9:14 9:18 4 min.
Discussion. .
Discussion
186004
315
5 9:18 9:38 20 min.
Saad Abdel Rahman. Alexandria. Egypt
Sudden cardiac death
186005
254
6 9:38 9:42 4 min.
Discussion. .
Discussion
186006
315
7 9:42 10:02 20 min.
Antar Khalaf. Suez Canal. Egypt
Right heart catheterization
186007
70
8 10:02 10:06 4 min.
Discussion. .
Discussion
186008
315
9 10:06 10:26 20 min.
Mohamed Shamardan. Bani Sweif. Egypt
What is the role of NOACS?
186009
216
10 10:26 10:30 4 min.
Discussion. .
Discussion
186010
315
Page | 60
Prepared by RM Solutions | www.rmsolutions.net
61. PROGRAM BY HALL
Al Manial
187
10:30
11:30
Al Manial
Nursing & Tech. (2) Challenging competition
Nurs/ Tech Track Session
Thu 18-2
*
Chairperson
Amr Salem
Hanan Farahat
Karima Mohamed
Saad Abdel Rahman
188
12:30
13:30
Al Manial
Bayer Workshop
Workshop Workshop
Thu 18-2
*
Page | 61
Prepared by RM Solutions | www.rmsolutions.net
62. PROGRAM BY HALL
Al Manial
189
14:30
16:30
Al Manial
Nursing & Tech. (3)
Nurs/ Tech Track Session
Thu 18-2
*
Chairperson
Ayman Hassan
Belal Abdel Wahab
Mohamed Kamal
Mohamed Ragab
1 14:30 14:50 20 min.
Omar Nour El Din. Suez Canal. Egypt
Agitated saline bubble study
189001
236
2 14:50 14:54 4 min.
Discussion. .
Discussion
189002
315
3 14:54 15:14 20 min.
Hamam Mohamed. AHC. Egypt
Aortitis
189003
119
4 15:14 15:18 4 min.
Discussion. .
Discussion
189004
315
5 15:18 15:38 20 min.
Seleem Shehata. Bani Sweif. Egypt
Infection control in cath Lab
189005
268
6 15:38 15:42 4 min.
Discussion. .
Discussion
189006
315
7 15:42 16:02 20 min.
Mahmoud Abdel Latif. Cairo. Egypt
Radiation protection
189007
181
8 16:02 16:06 4 min.
Discussion. .
Discussion
189008
315
9 16:06 16:26 20 min.
Alaa Hassan. Al Nas Hospital. Egypt
Shock Wave therapy in cardiovascular disease
189009
52
10 16:26 16:30 4 min.
Discussion. .
Discussion
189010
315
Page | 62
Prepared by RM Solutions | www.rmsolutions.net
63. PROGRAM BY HALL
Al Manial
190
16:30
17:30
Al Manial
Workshop: Shock wave therapy in cardiovascular disease
Nurs/ Tech Track Workshop
Thu 18-2
*
Chairperson
Hesham Rezk
Karima Mohamed
Mohamed Ragab
Tarek Hosny
Page | 63
Prepared by RM Solutions | www.rmsolutions.net
64. PROGRAM BY HALL
AL Montaza 1
105
8:30
9:30
AL Montaza 1
Session 1: Nuclear Cardiology: Work Shop from the American
Society of Nuclear Cardiology (ASNC)
Nuclear Cardiology Track Workshop
Tue 16-2
*
1 8:30 9:30 60 min.
Dennis Calnon. . USA
Work Shop from the American Society of Nuclear Cardiology
(ASNC)
105001
841
107
9:30
10:30
AL Montaza 1
Session 2: Nuclear Cardiology: Optimization of nuclear cardiology
protocol
Nuclear Cardiology Track Session
Tue 16-2
*
Chairperson
Adel Allam
Ahmed Abdelaty
Alia Abdelfattah
Mona Rayan
1 9:30 9:45 15 min.
Robert Hendel. . USA
How do we select appropriate test and protocol for the
patients referred for MPI
107001
252
2 9:45 10:00 15 min.
Gregory Thomas. . USA
Maximizing diagnostic ability and risk assessment with
exercise stress
107002
115
3 10:00 10:15 15 min.
Leslee Shaw. . USA
Challenges in evaluation of heart disease in women
107003
173
4 10:15 10:30 15 min.
Discussion. .
Discussion
107004
315
Page | 64
Prepared by RM Solutions | www.rmsolutions.net
65. PROGRAM BY HALL
AL Montaza 1
109
10:30
11:30
AL Montaza 1
Session 3: Basic CMR
CMR Track Session
Tue 16-2
*
Chairperson
Eman El Sharkawy
Mohamed Mandour
Tamer Wasify
1 10:30 11:00 30 min.
Ahmed Asfour. Cairo. Egypt
Focused introduction to CMR
109001
454
2 11:00 11:30 30 min.
Abdalla Al Agha. Cairo. Egypt
Overview on indications and clinical uses of CMR
109002
1
111
12:30
13:30
AL Montaza 1
Session 4: Teaching CMR Cases
CMR Track Session
Tue 16-2
*
Chairperson
Abdalla Al Agha
Hesham El Zomer
Salah M. Eltahan
1 12:30 12:45 15 min.
Tamer Wasify. Military. Egypt
Case 1
111001
280
2 12:45 13:00 15 min.
Sara Bahaa. DAF. Egypt
Case 2
111002
265
3 13:00 13:15 15 min.
Mai Saber. NHI. Egypt
Case 3
111003
185
4 13:15 13:30 15 min.
Ahmed Asfour. Cairo. Egypt
Case 4
111004
454
Page | 65
Prepared by RM Solutions | www.rmsolutions.net
66. PROGRAM BY HALL
AL Montaza 1
113
14:30
15:30
AL Montaza 1
Session 5: Cardiac CT - CTCA Workshop
CT Track Workshop
Tue 16-2
*
Chairperson
Hassan Ebeid
Mohamed Ali
Sameh Elkaffas
1 14:30 14:45 15 min.
Mohamed Ali. Cairo. Egypt
Cardiac CT Anatomy and Nomenclature
113001
197
2 14:45 15:00 15 min.
Sameh Elkaffas. Cairo. Egypt
Coronary Calcium Score
113002
259
3 15:00 15:15 15 min.
Sameh Elkaffas. Cairo. Egypt
Case Reading 10 Cases Coronary Calcium Score
113003
259
4 15:15 15:30 15 min.
Sameh Elkaffas. Cairo. Egypt
Current Indications for Cardiac CTA
113004
259
116
8:30
9:30
AL Montaza 1
Session 1: Nuclear cardiology PET imaging; where do we stand?
Nuclear Cardiology Track Session
Wed 17-2
*
Chairperson
Adel Allam
Islam Shawky
Mohamed Mandour
Mohamed Yosry
1 8:30 8:45 15 min.
Randi Thompson. . USA
Patient selection for cardiac PET
116001
246
2 8:45 9:00 15 min.
Timothy M. Bateman. . USA
When is PET a better choice than SPECT
116002
291
3 9:00 9:15 15 min.
Ignasi Carrio. . Spain
Imaging of cardiac innervation
116003
150
4 9:15 9:30 15 min.
Discussion. .
Discussion
116004
315
Page | 66
Prepared by RM Solutions | www.rmsolutions.net
67. PROGRAM BY HALL
AL Montaza 1
117
9:30
10:30
AL Montaza 1
Session 2: Role of Nuclear cardiology in myocardial diseases
Nuclear Cardiology Track Session
Wed 17-2
*
Chairperson
Abdel Rahman Sharaf
Ahmed Abdelaty
Saher Azab
Salah M. Eltahan
1 9:30 9:45 15 min.
Ahmed Tawakol. . USA
Imaging Cardiovascular Inflammation
117001
48
2 9:45 10:00 15 min.
Prem Soman. . USA
Evaluation of cardiac Amyloidosis and new management
modalities
117002
242
3 10:00 10:15 15 min.
Ignasi Carrio. . Spain
PET/CT in the assessment of endocarditis
117003
150
4 10:15 10:30 15 min.
Discussion. .
Discussion
117004
315
120
12:30
13:30
AL Montaza 1
Session 3: CMR - Advanced CMR Cases
CMR Track Session
Wed 17-2
*
Chairperson
Ahmed Asfour
Moustafa Ismaeil
Sara Bahaa
1 12:30 12:45 15 min.
Abdalla Al Agha. Cairo. Egypt
Case 1
120001
1
2 12:45 13:00 15 min.
Mary Rabee. NHI. Egypt
Case 2
120002
189
3 13:00 13:15 15 min.
Moustafa Ismaeil. ACMC. Egypt
Case 3
120003
228
4 13:15 13:30 15 min.
Hesham El Zomer. Azhar. Egypt
Case 4
120004
141
Page | 67
Prepared by RM Solutions | www.rmsolutions.net
68. PROGRAM BY HALL
AL Montaza 1
122
14:30
15:30
AL Montaza 1
Session 4: Young investigators challenging CMR cases competition
CMR Track Session
Wed 17-2
*
Chairperson
Ahmed Asfour
Eman El Sharkawy
Sara Bahaa
1 14:30 14:45 15 min.
TBA. .
Case 1
122001
316
2 14:45 15:00 15 min.
TBA. .
Case 2
122002
316
3 15:00 15:15 15 min.
TBA. .
Case 3
122003
316
4 15:15 15:30 15 min.
TBA. .
Case 4
122004
316
124
15:30
16:30
AL Montaza 1
Session 5: Cardiac CT
CT Track Session
Wed 17-2
*
Chairperson
Hassan Ebeid
Islam Shawky
Salah M. Eltahan
1 15:30 15:45 15 min.
Mohamed Ali. Cairo. Egypt
Principles of cardiac CTA
124001
197
2 15:45 16:00 15 min.
Mohamed Ali. Cairo. Egypt
Case Reading 10 Cases CTA
124002
197
3 16:00 16:15 15 min.
Sameh Elkaffas. Cairo. Egypt
Tips and tricks in cardiac CTA
124003
259
4 16:15 16:30 15 min.
Sameh Elkaffas. Cairo. Egypt
Case Reading 10 Cases CTA
124004
259
Page | 68
Prepared by RM Solutions | www.rmsolutions.net
69. PROGRAM BY HALL
AL Montaza 1
127
8:30
9:30
AL Montaza 1
Session 1: Nuclear cardiology - Multimodality Imaging
Nuclear Cardiology Track Session
Thu 18-2
*
Chairperson
Alia Abdelfattah
Aly Abo Al Hoda
Azza El Fiky
Eman El Sharkawy
1 8:30 8:45 15 min.
Samuel Wann. . USA
Role of cardiac imaging in Arrhythmia management
127001
263
2 8:45 9:00 15 min.
Vasken Dilsizian. . USA
Multimodality imaging in Infective endocarditis
127002
295
3 9:00 9:15 15 min.
Saher Azab. Alexandria. Egypt
Multimodality imaging in pulmonary hypertension
127003
469
4 9:15 9:30 15 min.
Discussion. .
Discussion
127004
315
128
9:30
10:30
AL Montaza 1
Session 2: Nuclear cardiology - Meet with experts
Nuclear Cardiology Track Session
Thu 18-2
*
Chairperson
Akram Abdelbary
Aziz Madkour
Salah Demerdash
1 9:30 9:45 15 min.
Adel Allam. . Egypt
Al Azher Univ. Lab.Experience
128001
10
2 9:45 10:00 15 min.
Alia Abdelfattah. Cairo. Egypt
Cairo Univ. Lab. Experience
128002
55
3 10:00 10:15 15 min.
Ahmed Abdelaty. Alexandria. Egypt
Applying SPECT Appropriate use criteria in Alexandria Nuclear
Cardiology Lab
128003
20
4 10:15 10:30 15 min.
Discussion. .
Discussion
128004
315
Page | 69
Prepared by RM Solutions | www.rmsolutions.net
70. PROGRAM BY HALL
AL Montaza 1
129
10:30
11:30
AL Montaza 1
Session 3: Cardiac CT in clinical practice
CT Track Session
Thu 18-2
*
Chairperson
Adel Allam
Ahmed Magdi
Akram Abdelbary
Sameh Elkaffas
1 10:30 10:45 15 min.
Mohamed Ali. Cairo. Egypt
Special cases; anomalies, stents, grafts
129001
197
2 10:45 11:00 15 min.
Hassan Ebeid. Fayoum. Egypt
Coronary Calcium score guided CV prevention
129002
129
3 11:00 11:15 15 min.
Islam Shawky. Azhar. Egypt
Cardiac CT vs nuclear MPI in Stable ischemic heart disease
129003
154
4 11:15 11:30 15 min.
Stephan Achenbach. . Germany
Role of CTCA in Emergency department
129004
277
130
12:30
13:30
AL Montaza 1
Session 4: CT-guided structural cardiac intervention; role of
cardiac CT
CT Track Session
Thu 18-2
*
Chairperson
Hassan Ebeid
Islam Shawky
Sameh Elkaffas
1 12:30 12:45 15 min.
Rania Zakaria. Cairo. Egypt
CT in Pre- and Post-Operative Congenital heart disease
130001
247
2 12:45 13:00 15 min.
Ahmed Magdi. NHI. Egypt
TAVI
130002
34
3 13:00 13:15 15 min.
Jonathtan Leipsic. . Canada
Left Atrial Appendage Closure and Transcatheter Mitral Valve
Procedures
130003
157
4 13:15 13:30 15 min.
Discussion. .
Discussion
130004
315
Page | 70
Prepared by RM Solutions | www.rmsolutions.net
71. PROGRAM BY HALL
AL Montaza 1
131
14:30
15:30
AL Montaza 1
Session 5: CT in Functional coronary assessment; FFR-CT
CT Track Session
Thu 18-2
*
Chairperson
Adel El Etriby
Mohamed Ali
Rania Zakaria
Saher Azab
1 14:30 14:45 15 min.
Sameh Elkaffas. Cairo. Egypt
Rationale behind FFR-CT
131001
259
2 14:45 15:00 15 min.
Eman El Sharkawy. Alexandria. Egypt
What does the literature say?
131002
96
3 15:00 15:15 15 min.
Nick Curzen. . UK
Cost-effectiveness of FFR-CT; insights from FORECAST trial
131003
232
4 15:15 15:30 15 min.
Discussion. .
Discussion
131004
315
204
15:30
16:30
AL Montaza 1
Session 3: Nuclear cardiology - Young Investigators Award
Nuclear Cardiology Track Session
Thu 18-2
*
Chairperson
Adel Allam
Ahmed Abdelaty
Alia Abdelfattah
Islam Shawky
Saher Azab
1 15:30 15:45 15 min.
TBA. .
Case 1
204001
316
2 15:45 16:00 15 min.
TBA. .
Case 2
204002
316
3 16:00 16:15 15 min.
TBA. .
Case 3
204003
316
4 16:15 16:30 15 min.
TBA. .
Case 4
204004
316
Page | 71
Prepared by RM Solutions | www.rmsolutions.net
72. PROGRAM BY HALL
AL Montaza 1-2-3-4
98
10:00
11:00
AL Montaza 1-2-3-4
Session 1: Multimodality Imaging of Aortopathies
Multimodality Track Session
Mon 15-2
*
Chairperson
Ahmed Asfour
Amal Abdel Salam
Dina Osama
1 10:00 10:15 15 min.
Ahmed Fareed. Suez Canal. Egypt
TEE in Acute Aortic Syndromes& Trauma
098001
451
2 10:15 10:30 15 min.
Hazem Hamed. Cairo. Egypt
Role of CT in preoperative Decision Making
098002
452
3 10:30 10:45 15 min.
Sarah Moharem Elgamal. . UK
Is CMR is Better for the Aorta
098003
404
4 10:45 11:00 15 min.
Said Abdel Aziz. Cairo. Egypt
Patient Selection for Surgical vs Endovascular Aortic Repair
098004
255
99
11:00
12:00
AL Montaza 1-2-3-4
Session 2: Is Cardiac Amyloidosis a rare disease? How Can
Cardiac Imaging help?
Multimodality Track Session
Mon 15-2
*
Chairperson
Adel Allam
Hesham Aboul Enien
Mohamed El-Noamany
Mohamed Ossama
Salah M. Eltahan
1 11:00 11:15 15 min.
Hany Ragy. NHI. Egypt
What a Cardiologist needs to Know about Amyloidosis
099001
128
2 11:15 11:30 15 min.
Richard Steeds. . UK
Left Ventricular Hypertrophy: Differential Diagnosis
099002
250
3 11:30 11:45 15 min.
Abdalla Al Agha. Cairo. Egypt
CMR, when to use and Why?
099003
1
4 11:45 12:00 15 min.
Sharmila Durbala. . USA
The Days of Endomyocardial Biopsy is Over for ATTR
Amyloidosis. PYP Imaging Has Changed The Guidelines
099004
269
Page | 72
Prepared by RM Solutions | www.rmsolutions.net
73. PROGRAM BY HALL
AL Montaza 1-2-3-4
100
12:00
13:00
AL Montaza 1-2-3-4
Session 3: Multimodality imaging in coronary artery disease
Multimodality Track Session
Mon 15-2
*
Chairperson
Alia Abdelfattah
Aziz Madkour
Kawkab Khedr
Tarek Naguib
1 12:00 12:15 15 min.
Zainab Abdel Salam. Ain Shams. Egypt
Stress Echicardiography Role in CAD and Recent Advances
100001
453
2 12:15 12:30 15 min.
Leslee Shaw. . USA
CTA Should Precede Functional Imaging. In Which Patient
Population and Why?
100002
173
3 12:30 12:45 15 min.
Prem Soman. . USA
SPECT: What are The Recent Advances and When Should We
Use PET?
100003
242
4 12:45 13:00 15 min.
Ahmed Asfour. Cairo. Egypt
CMR; Is the One Stop Shop Dream Still Alive?
100004
454
101
13:00
14:00
AL Montaza 1-2-3-4
Session 4: Cardiac Imaging in Heart Failure
Multimodality Track Session
Mon 15-2
*
Chairperson
Adel Allam
Azza Farag
Hanna Freag
Ikram Sadek
1 13:00 13:20 20 min.
Mona Abulsoud. Ain Shams. Egypt
Echocardiography: Going Beyond EF
101001
455
2 13:20 13:40 20 min.
Ahmed Tawakol. . USA
Brain Heart Connection for atherosclerotic Inflammation and
CVD
101002
48
3 13:40 14:00 20 min.
Alia Abdelfattah. Cairo. Egypt
Nuclear Cardiology: From Simple Assessment of Global and
Regional Function TO Sympathetic Innervation and
Dyssynchrony
101003
55
Page | 73
Prepared by RM Solutions | www.rmsolutions.net
74. PROGRAM BY HALL
AL Montaza 1-2-3-4
102
14:00
15:00
AL Montaza 1-2-3-4
Session 5: Hybrid Imaging
Multimodality Track Session
Mon 15-2
*
Chairperson
Ahmed Abdelaty
Islam Shawky
Maged Al Abbady
Mona Rayan
1 14:00 14:20 20 min.
Randi Thompson. . USA
SPECT and PET/CT
102001
246
2 14:20 14:40 20 min.
Ahmed Tawakol. . USA
Multimodality Imaging of Atherosclerosis
102002
48
3 14:40 15:00 20 min.
Hala Mahfouz. Menofia. Egypt
Recent Advantages in the Field of Echocardiography
102003
118
103
15:00
16:00
AL Montaza 1-2-3-4
Session 6: Multimodality Imaging in Common Scenarios
Multimodality Track Session
Mon 15-2
*
Chairperson
Hala Mahfouz
Hossam El Gendi
Mohamed Ossama
1 15:00 15:15 15 min.
Hossam El Gendi. . UK
Imaging of pericardial Diseases
103001
457
2 15:15 15:30 15 min.
Mohamed El-Noamany. Menofia. Egypt
RV: Is not the Forgotten Chamber any more
103002
200
3 15:30 15:45 15 min.
Roberto Lang. . USA
Mitral Regurgitation Debate: Echo is all I Need
103003
253
4 15:45 16:00 15 min.
Richard Steeds. . UK
Mitral Regurgitation Debate: Echo is not enough
103004
250
Page | 74
Prepared by RM Solutions | www.rmsolutions.net
75. PROGRAM BY HALL
AL Montaza 1-2-3-4
104
16:00
17:00
AL Montaza 1-2-3-4
Session 7: Multimodality Case Presentation
Multimodality Track Session
Mon 15-2
*
Chairperson
Amr Al-badry
Eman El Sharkawy
Hanna Abdel Aziz
Sarah Moharem Elgamal
1 16:00 16:15 15 min.
TBA. .
Case 1
104001
316
2 16:15 16:30 15 min.
TBA. .
Case 2
104002
316
3 16:30 16:45 15 min.
TBA. .
Case 3
104003
316
4 16:45 17:00 15 min.
TBA. .
Case 4
104004
316
Page | 75
Prepared by RM Solutions | www.rmsolutions.net
76. PROGRAM BY HALL
AL Montaza 2-3-4
106
9:00
10:00
AL Montaza 2-3-4
Workshop: 3D Transeosophageal Echo (Image Acquisition and
display)
Echo Track Workshop
Tue 16-2
*
1 9:00 10:00 60 min.
Hani Mahmoud. Al Nas Hospital. Egypt
Workshop: 3D Transeosophageal Echo (Image Acquisition and
display)
106001
123
108
10:00
11:00
AL Montaza 2-3-4
Session 8: Echocardiographic Assessment of Critically ill patient
Echo Track Session
Tue 16-2
*
Chairperson
Laila Maghawry
Mohamed Ossama
Mona Abulsoud
Walaa Adel
1 10:00 10:15 15 min.
Hatem Soliman. . UK
Volume Assessment of patient in Shock
108001
132
2 10:15 10:30 15 min.
Hala Mahfouz. Menofia. Egypt
FOCUS in Acute Heart Failure
108002
118
3 10:30 10:45 15 min.
Hatem Soliman. . UK
Echo in Mechanical Circulatory Support
108003
132
4 10:45 11:00 15 min.
Hatem Soliman. . UK
Echo During Cardiac Arrest
108004
132
Page | 76
Prepared by RM Solutions | www.rmsolutions.net
77. PROGRAM BY HALL
AL Montaza 2-3-4
110
12:30
13:30
AL Montaza 2-3-4
Session 9: Stress Echo: New updates and more
Echo Track Session
Tue 16-2
*
Chairperson
Farid Doala
Ghada El Shahed
Mohamed Osman
Walaa Farid
1 12:30 12:45 15 min.
Aly galal. NHI. Egypt
Guidelines Updates for IHD
110001
459
2 12:45 13:00 15 min.
Richard Steeds. . UK
Role of Contrast in Stress Echocardiography
110002
250
3 13:00 13:15 15 min.
Amal Khalifa. Cairo. Egypt
Stress Echo: Not Just for CAD, GET with the Guidelines
110003
460
4 13:15 13:30 15 min.
Laila Maghawry. Zagazig. Egypt
Stress Echo for Low Flow Low Gradient Aortic Stenosis:
protocol and Workflow
110004
461
112
14:30
15:30
AL Montaza 2-3-4
Session 10: Systematic Approach for evaluation of Valves
Echo Track Session
Tue 16-2
*
Chairperson
Ghada Sayed Youssef
Heba El Naggar
Iglal Abdel Aziz
Tarek Aziz
1 14:30 14:45 15 min.
Victor Fadlallah. NHI. Egypt
ASE/ESC Guidelines for Assessment of Prosthetic Valves
112001
462
2 14:45 15:00 15 min.
Mohamed Ayman Abdel Hay. Alexandria. Egypt
Distinguishing Aortic Prosthesis Patient Mismatch from
Dysfunction
112002
463
3 15:00 15:15 15 min.
Mohamed Naseem. Tanta. Egypt
Echo Assessment Pre-valve in valve Procedure
112003
486
4 15:15 15:30 15 min.
Sameh Zaghloul. Cairo. Egypt
Prosthetic valve endocarditis (Echo Role)
112004
465
Page | 77
Prepared by RM Solutions | www.rmsolutions.net
78. PROGRAM BY HALL
AL Montaza 2-3-4
114
15:30
16:30
AL Montaza 2-3-4
Session 11: The Value of the third dimension
Echo Track Session
Tue 16-2
*
Chairperson
Essam Baliegh
Hoda Shehata
Karim Mahmoud
Tarek Aziz
1 15:30 15:45 15 min.
Azza Farag. Cairo. Egypt
3-D vs 2-D Volumes: Worth the effort?
114001
80
2 15:45 16:00 15 min.
Ahmed Mohsen. Cairo. Egypt
3-D Explains what 2-D Couldn't
114002
466
3 16:00 16:15 15 min.
Roberto Lang. . USA
Mitral Regurgitation, what can 3-D Add?
114003
253
4 16:15 16:30 15 min.
Hani Mahmoud. Al Nas Hospital. Egypt
3-D TEE in Mitral Paravalvular Leak
114004
123
115
16:30
17:30
AL Montaza 2-3-4
Session 12: Echocardiography Case Presentations
Echo Track Session
Tue 16-2
*
Chairperson
Ahmed Adel Elamragy
Ghada Kazamel
Islam Al-Sherbiny
Noha Hassanin
Salma Taha
1 16:30 16:45 15 min.
TBA. .
Case 1
115001
316
2 16:45 17:00 15 min.
TBA. .
Case 2
115002
316
3 17:00 17:15 15 min.
TBA. .
Case 3
115003
316
4 17:15 17:30 15 min.
TBA. .
Case 4
115004
316
Page | 78
Prepared by RM Solutions | www.rmsolutions.net
79. PROGRAM BY HALL
AL Montaza 2-3-4
118
8:30
10:00
AL Montaza 2-3-4
Workshop: Tips and Tricks in 2D Echocardiography Deformation
Analysis
Echo Track Workshop
Wed 17-2
*
1 8:30 10:00 90 min.
Shehab Anwar. . Switzerland
Basics of Deformation.
LV Longitudinal Strain.
LV Circumferential and Radial Strain
Lv Rotation and Mechanics.
Understanding Deformation Rate
118001
499
119
10:00
11:00
AL Montaza 2-3-4
Session 13: Speckle Tracking: Early Detection of Myocardial
Deformation Imaging
Echo Track Session
Wed 17-2
*
Chairperson
Amal Khalifa
Heba El Naggar
Said Shalaby
Salwa Ghoniem
Zainab Abdel Salam
1 10:00 10:15 15 min.
Rehab Mohamed Hamdy. Azhar. Egypt
Debate; Global Longitudinal Strain: Should always be Added
119001
471
2 10:15 10:30 15 min.
Mohamed Mohsen. NHI. Egypt
Debate; Global Longitudinal Strain: VS is not Needed in
Evaluation of LV Function
119002
472
3 10:30 10:45 15 min.
Shaymaa Moustafa. Benha. Egypt
Strain in Valve Disease
119003
473
4 10:45 11:00 15 min.
Said Shalaby. Menofia. Egypt
Deformation and Twist in Heart Failure with Normal EF
119004
474
Page | 79
Prepared by RM Solutions | www.rmsolutions.net
80. PROGRAM BY HALL
AL Montaza 2-3-4
121
12:30
13:30
AL Montaza 2-3-4
Session 14: Adult congenital Heart Disease for Adult
Sonographers
Echo Track Session
Wed 17-2
*
Chairperson
Hala Elmarsafawy
Ikram Massoud
Maiy Hamdy Elsayed
Safaa Husien
Sahar Elshedoudy
1 12:30 12:45 15 min.
Amal Abdel Salam. NHI. Egypt
The Adult with Unrepaired Shunt
121001
475
2 12:45 13:00 15 min.
Ghada El Shahed. Ain shams. Egypt
Ebstien Anomaly
121002
477
3 13:00 13:15 15 min.
Raghda Elshiekh. Tanta. Egypt
TOF in Adults
121003
476
4 13:15 13:30 15 min.
Sherien Abdel Salam. Al Nas Hospital. Egypt
How to Evaluate Post TGA Repairs: Arterial Switch , Mustard
/Senning Operation
121004
478
Page | 80
Prepared by RM Solutions | www.rmsolutions.net
81. PROGRAM BY HALL
AL Montaza 2-3-4
123
14:30
15:30
AL Montaza 2-3-4
Session 15: Valves & more
Echo Track Session
Wed 17-2
*
Chairperson
Hala Mahfouz
Hamza Kabil
Karim Mahmoud
Osama Refaei
Ragab Abdelsalam
1 14:30 14:45 15 min.
Richard Steeds. . UK
Aortic Stenosis (The Valve and The Ventricle
123001
250
2 14:45 15:00 15 min.
Ralph Stephen Von Bardeleben. . Germany
Mitral Valve Intervention: Role of Imanging in Mitral Clip
Procedure
123002
244
3 15:00 15:15 15 min.
Roberto Lang. . USA
Transillumination and Beyond: New Ways to
Improve 3D Rendering
123003
253
4 15:15 15:30 15 min.
Hani Mahmoud. Al Nas Hospital. Egypt
3D Echo Utility in Mitral Stenosis
123004
123
125
15:30
16:30
AL Montaza 2-3-4
Session 16: Innovations & updates
Echo Track Session
Wed 17-2
*
Chairperson
Ahmed Magdy Mostafa
Azza El Fiky
Reda Abuelatta
Sanaa Ashour
1 15:30 15:50 20 min.
Ralph Stephen Von Bardeleben. . Germany
Transcatheter Tricuspid Valve Repair: Feasibility Given on the
Way to Benefit?
125001
244
2 15:50 16:10 20 min.
Roberto Lang. . USA
Virtual Reality Meets Echocardiography
125002
253
3 16:10 16:30 20 min.
Richard Steeds. . UK
Timing of Surgery in Primary MR
125003
250
Page | 81
Prepared by RM Solutions | www.rmsolutions.net
82. PROGRAM BY HALL
AL Montaza 2-3-4
126
16:30
17:30
AL Montaza 2-3-4
Session 17: Echocardiography Case Presentation 3
Echo Track Session
Wed 17-2
*
Chairperson
Ahmed Fathi
Heba El-Deeb
Mai Salama
Manar Al zaky
Sameh Bakhom
1 16:30 16:45 15 min.
TBA. .
Case 1
126001
316
2 16:45 17:00 15 min.
TBA. .
Case 2
126002
316
3 17:00 17:15 15 min.
TBA. .
Case3
126003
316
4 17:15 17:30 15 min.
TBA. .
Case 4
126004
316
Page | 82
Prepared by RM Solutions | www.rmsolutions.net
83. PROGRAM BY HALL
AL Montaza 2-3-4
132
9:30
10:30
AL Montaza 2-3-4
Session 2: Hypertension guidelines
Hypertension Track Session
Thu 18-2
*
Chairperson
Mahmoud Abdelsabour
Marwa Mohamed gad
Mohamed Naseem
Mohsen Ibrahim
Omar Awaad
Samia Mahmoud Sharaf El Din
1 9:30 9:42 12 min.
Ahmed Abdel Rahman. Ain Shams. Egypt
ISH 2020 guidelines, Is there any new message?
132001
19
2 9:42 9:45 3 min.
Discussion. .
Discussion
132002
315
3 9:45 9:57 12 min.
Ramez Guindy. Ain Shams. Egypt
Guidelines and Gap in Evidence
132003
487
4 9:57 10:00 3 min.
Discussion. .
Discussion
132004
315
5 10:00 10:12 12 min.
Hatem Elsokkary. Tanta. Egypt
The missing part of the puzzle, Message from guidelines to
stakeholders
132005
131
6 10:12 10:15 3 min.
Discussion. .
Discussion
132006
315
7 10:15 10:27 12 min.
Omar Awaad. Ain Shams. Egypt
Whether American and European can be applied in Egypt?
132007
233
8 10:27 10:30 3 min.
Discussion. .
Discussion
132008
315
Page | 83
Prepared by RM Solutions | www.rmsolutions.net
84. PROGRAM BY HALL
AL Montaza 2-3-4
133
10:30
11:30
AL Montaza 2-3-4
CPR in the armamentarium of cardiac patient care
Medical Track Session
Thu 18-2
*
Chairperson
Khaled Elkhashab
Khalid El Rabbat
1 10:30 10:40 10 min.
Hany El Shahidy. NHI. Egypt
CPR in Covid19 " AHA guidlines 2020 "
133001
488
2 10:40 10:42 2 min.
Discussion. .
Discussion
133002
315
3 10:42 10:52 10 min.
Mohamed Gharieb. NCHI. Egypt
CPR in Cath Lab
133003
334
4 10:52 10:54 2 min.
Discussion. .
Discussion
133004
315
5 10:54 11:04 10 min.
Tarek El Khouly. NHI. Egypt
CPR recent update
133005
282
6 11:04 11:06 2 min.
Discussion. .
Discussion
133006
315
7 11:06 11:16 10 min.
Yasser Hosny. Benha. Egypt
CPR in Atheletes in COVID19 Era
133007
489
8 11:16 11:18 2 min.
Discussion. .
Discussion
133008
315
9 11:18 11:28 10 min.
Yasser Yazid. . Egypt
CPR in special Situation
133009
490
10 11:28 11:30 2 min.
Discussion. .
Discussion
133010
315
Page | 84
Prepared by RM Solutions | www.rmsolutions.net
85. PROGRAM BY HALL
AL Montaza 2-3-4
134
12:30
13:30
AL Montaza 2-3-4
Cardio-Covid - Session "1" From pathogenesis to diagnosis “All
the story of cardio-virology”
Medical Track Session
Thu 18-2
*
Chairperson
Diaa Elmenshawy
Ragab Abdelsalam
Sherif Seif
Tarek Abdelghafar
1 12:30 12:42 12 min.
Hisham Selim. NHI. Egypt
Myocardial injury
134001
492
2 12:42 12:45 3 min.
Discussion. .
Discussion
134002
315
3 12:45 12:57 12 min.
TBA. .
Viral Pericarditis
134003
316
4 12:57 13:00 3 min.
Discussion. .
Discussion
134004
315
5 13:00 13:12 12 min.
Nasser Taha. Minia. Egypt
Arterial affection the whole spectrum
134005
230
6 13:12 13:15 3 min.
Discussion. .
Discussion
134006
315
7 13:15 13:27 12 min.
Mohamed Abdel Shafy. Benha. Egypt
Veneous thrombo-embolism
134007
494
8 13:27 13:30 3 min.
Discussion. .
Discussion
134008
315
Page | 85
Prepared by RM Solutions | www.rmsolutions.net
86. PROGRAM BY HALL
AL Montaza 2-3-4
135
14:30
15:30
AL Montaza 2-3-4
Cardio-Covid - Session "2" The good, the bad and the ugly in
Cardio-COVID management
Medical Track Session
Thu 18-2
*
Chairperson
Gamal Aboul Nasr
Hassan Baky
Mohamed Wafaie Aboul Enien
Nady Michel
Ramez Sam
1 14:30 14:42 12 min.
Tamer Moustafa. Zagazig. Egypt
Triage both COVID-19 and cardiac problems, an algorithmic
approach
135001
279
2 14:42 14:45 3 min.
Discussion. .
Discussion
135002
315
3 14:45 14:57 12 min.
Ghada Kazamel. NHI. Egypt
Management of COVID-19 between healthcare teams
135003
112
4 14:57 15:00 3 min.
Discussion. .
Discussion
135004
315
5 15:00 15:12 12 min.
Mahmoud Hassanin. Alexandria. Egypt
Late and very late COVID-19 CVD complication, an alertness
call
135005
449
6 15:12 15:15 3 min.
Discussion. .
Discussion
135006
315
7 15:15 15:27 12 min.
Victor Fadlallah. NHI. Egypt
Corticosteroids and anticoagulation? When, how and to
whom?
135007
462
8 15:27 15:30 3 min.
Discussion. .
Discussion
135008
315
Page | 86
Prepared by RM Solutions | www.rmsolutions.net
87. PROGRAM BY HALL
AL Montaza 2-3-4
136
15:30
16:00
AL Montaza 2-3-4
Cardio-Covid - Session "3"
Medical Track Session
Thu 18-2
*
Chairperson
Hamdy Soliman
Khaled Elnady
Khaled Shokry
Samir Rafla
1 15:30 16:00 30 min.
Fausto Pinto. . Portugal
A state of art lecture: Cardiovascular Disease in Pandemic
Times
136001
438
Page | 87
Prepared by RM Solutions | www.rmsolutions.net
88. PROGRAM BY HALL
AL Montaza 2-3-4
137
16:00
17:00
AL Montaza 2-3-4
TeleHealth
Medical Track Session
Thu 18-2
*
Chairperson
Waleed Abbas
1 16:00 16:12 12 min.
Nader Tadross. .
Shaking the Medical Care Paradigm, lessons from COVID-19
era
Faculty affiliations in several US medical institutions
137001
498
2 16:12 16:15 3 min.
Discussion. .
Discussion
137002
315
3 16:15 16:27 12 min.
Shehab Anwar. . Switzerland
Patients communication platforms
137003
499
4 16:27 16:30 3 min.
Discussion. .
Discussion
137004
315
5 16:30 16:42 12 min.
Shehab Anwar. . Switzerland
State of art in the interpretation of cardiac imaging by
machine learning
137005
499
6 16:42 16:45 3 min.
Discussion. .
Discussion
137006
315
7 16:45 16:57 12 min.
Mamas Mamas. . UK
Electronic health records: a limitation of retrospective data or
a potential information mine
137007
501
8 16:57 17:00 3 min.
Discussion. .
Discussion
137008
315
Page | 88
Prepared by RM Solutions | www.rmsolutions.net
89. PROGRAM BY HALL
AL Montaza 2-3-4
138
17:00
18:00
AL Montaza 2-3-4
Best of National Cases: Revise with the experts “3”
Medical Track Session
Thu 18-2
*
Chairperson
Mohaned Egred
Waleed Abbas
1 17:00 17:08 8 min.
TBA. .
Case 1
138001
316
2 17:08 17:12 4 min.
Discussion. .
Discussion
138002
315
3 17:12 17:20 8 min.
TBA. .
Case 2
138003
316
4 17:20 17:24 4 min.
Discussion. .
Discussion
138004
315
5 17:24 17:32 8 min.
TBA. .
Case 3
138005
316
6 17:32 17:36 4 min.
Discussion. .
Discussion
138006
315
7 17:36 17:44 8 min.
TBA. .
Case 4
138007
316
8 17:44 17:48 4 min.
Discussion. .
Discussion
138008
315
9 17:48 17:56 8 min.
TBA. .
Case 5
138009
316
10 17:56 18:00 4 min.
Discussion. .
Discussion
138010
315
Page | 89
Prepared by RM Solutions | www.rmsolutions.net
90. PROGRAM BY HALL
Al Saraya 1
1
10:00
11:30
Al Saraya 1
EgSCi, Session "1" EAZI (Egypt A-Z Intervention) Fellow Course
NIA (National Interventional Academy)
Intervention Ischemia Track Session
Mon 15-2
*
Chairperson
Alaa Hataba
Khaled Eltohamy
Maged Ramses
Mohamed Ossama
Sherif El Tobgy
1 10:00 10:15 15 min.
Maged Al Abbady. NHI. Egypt
Coronary Interventional Views and Imaging Tips for PCI
001001
313
2 10:15 10:30 15 min.
Walid Ammar. Cairo. Egypt
Guiding Catheter Selection in Challenging Anatomy, Case
Based
001002
301
3 10:30 10:45 15 min.
Ahmed Sabry. Military. Egypt
Guide Wire Design, Selection for which Lesion
001003
44
4 10:45 11:00 15 min.
Ramy Omar. NHI. Egypt
Contrast Induced Nephropathy
001004
314
5 11:00 11:15 15 min.
Sandeep Nathan. . USA
PCI Complications How to Avoid
001005
264
6 11:15 11:30 15 min.
Ehab El Yamany. Bani Sweif. Egypt
No- reflow controverse
001006
703
Page | 90
Prepared by RM Solutions | www.rmsolutions.net
91. PROGRAM BY HALL
Al Saraya 1
2
11:30
12:30
Al Saraya 1
EgSCi, Session "2" EAZI(Egypt A-Z Intervention)/ Radial Summit:
Advances in Procedural Techniques Session
Intervention Ischemia Track Session
Mon 15-2
*
Chairperson
Ahmad Mohamed Fathy
Anas Elbadawi
Essam Baliegh
Hesham Aboul Enien
Mohamed Zaki
Tarek Zaki
1 11:30 11:42 12 min.
Ahmed Rezk. Ain Shams. Egypt
Step by step technique, cocktail, anticoagulation
002001
42
2 11:42 11:54 12 min.
Samir Pancholy. . USA
Dealing with difficult anatomy, learn from cases
002002
262
3 11:54 12:06 12 min.
Samir Pancholy. . USA
Radial Artery complications Occlusion Prevention and
Recanalization
002003
262
4 12:06 12:18 12 min.
Khaled Refaat. Bani Sweif. Egypt
Learn from cases
002004
167
5 12:18 12:30 12 min.
Mansour Sallam. Ain Shams. Egypt
Learn from cases
002005
187
Page | 91
Prepared by RM Solutions | www.rmsolutions.net
92. PROGRAM BY HALL
Al Saraya 1
3
12:30
14:00
Al Saraya 1
EgSCi, Session "3" Challenges with Primary PCI I
Intervention Ischemia Track Session
Mon 15-2
*
Chairperson
Ahmed Shafie Ammar
Amr El Guindy
Ashraf Reda
Hesham Hegazy
Mohamed Emam
Mounier Osman
Nasser Taha
1 12:30 12:42 12 min.
Gamal Ahmed Abdelhafiez. Police Hospital. Egyp
PPCI in Complex anatomy
003001
701
2 12:42 12:54 12 min.
Mohamed Mosaad. Azhar. Egypt
Complex case scenario
003002
324
3 12:54 13:06 12 min.
Ahmed Kamel. NHI. Egypt
Complex case scenario
003003
33
4 13:06 13:18 12 min.
Mohamed Atef. Ain Shams. Egypt
Case presentation
003004
317
5 13:18 13:30 12 min.
Abdelrahman Elbokary. NHI. Egypt
Complex case scenario
003005
5
6 13:30 13:42 12 min.
Mohamed Khedr. Military. Egypt
Case presentation
003006
329
7 13:42 13:54 12 min.
Amr Emam. NHI. Egypt
Case presentation
003007
827
Page | 92
Prepared by RM Solutions | www.rmsolutions.net
93. PROGRAM BY HALL
Al Saraya 1
4
14:00
15:30
Al Saraya 1
EgSCi, Session "4" EAZI( Egypt A-Z Intervention) / Coronary
Imaging To Optimize Outcome Lesion Subsets/ Coronary Imaging
"Zoom"
Intervention Ischemia Track Session
Mon 15-2
*
Chairperson
Amin Fouad
Haitham Badran
Helmy El Ghawaby
Hossam Mesbah
Ihab Daoud Hanna
Mohamed Eid Fawzy
Sameh Emil
1 14:00 14:15 15 min.
Mohamed Abo Bakr. NHI. Egypt
IVUS Can Help Me Perform PCI Better? Case Based
004001
700
2 14:15 14:30 15 min.
Ramesh Daggubati. . USA
OCT, what do you need to see?
004002
245
3 14:30 14:45 15 min.
Adam Witkowski. . Poland
Physiologic imaging, FFR?
004003
9
4 14:45 15:00 15 min.
Sameh Elkaffas. Cairo. Egypt
CT Angiography an addition not competition
004004
259
5 15:00 15:15 15 min.
Chalak Berzingi. . USA
Integration of imaging modalities, case based
004005
848
6 15:15 15:30 15 min.
Sayed Abdou. . KSA
Role of imaging in calcified lesions, case based
004006
267
Page | 93
Prepared by RM Solutions | www.rmsolutions.net
94. PROGRAM BY HALL
Al Saraya 1
5
15:30
17:00
Al Saraya 1
EgSCi, Session "5" Challenges With Primary PCI II: Complications
and challenging situations during primary PCI
Intervention Ischemia Track Session
Mon 15-2
*
Chairperson
Ahmed Khashaba
Ahmed Magdi
Gamal Aboul Nasr
Hanna Noseir
Mohamed Abdelghany
Omar Awaad
Sherif El Tobgy
1 15:30 15:45 15 min.
Sandeep Nathan. . USA
Case escalation tricks in primary PCI
005001
264
2 15:45 16:00 15 min.
Hany Ragy. NHI. Egypt
Optimizing revascularization in Primary PCI
005002
128
3 16:00 16:15 15 min.
Khaled Eltohamy. NHI. Egypt
Primary PCI in complex anatomy
005003
165
4 16:15 16:30 15 min.
Hany Eteiba. . UK
Management of massive coronary thrombi
005004
126
5 16:30 16:45 15 min.
Nereen Okasha. Ain Shams. Egypt
PPCI in Complex anatomy
005005
231
6 16:45 17:00 15 min.
Sherif Hussein. MUST. Egypt
MI due to stent thrombosis
005006
273
Page | 94
Prepared by RM Solutions | www.rmsolutions.net
95. PROGRAM BY HALL
Al Saraya 1
6
9:00
10:30
Al Saraya 1
EgSCi, Session "6" Intervention/ Intervention Updates, Where we
are in 2021
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Adel El Etriby
Ihab Attia
Khaled Shokry
Mohamed Ossama
1 9:00 9:18 18 min.
Ahmed Shawky. Ain Shams. Egypt
Late intervention clinical trials in 2020
006001
46
2 9:18 9:36 18 min.
Mohamed Seleem. NHI. Egypt
10 points to remember from intervention guidelines
006002
215
3 9:36 9:54 18 min.
Luca Testa. . Italy
10 commands to make successful bifurcation intervention
006003
174
4 9:54 10:12 18 min.
Adnan Kastrati. . Germany
Drug Eluting Stents latest updates
006004
15
5 10:12 10:30 18 min.
Mohaned Egred. . UK
How far CTO intervention Can go ?
006005
502
Page | 95
Prepared by RM Solutions | www.rmsolutions.net
96. PROGRAM BY HALL
Al Saraya 1
7
10:30
11:30
Al Saraya 1
EgSCi, Session "7" Optimizing Bifurcation Intervention I, EBC
Joint with EgBC of EgIC
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Ahmed Emara
Ahmed Nassar
Alaa Hataba
Ayman Saleh
Hossam Kandil
Sameh Samir
Sherif El Tobgy
1 10:30 10:45 15 min.
Luca Testa. . Italy
Bifurcations intervention 2021: new classifications, new
strategies, new techniques for different lesions
007001
174
2 10:45 11:00 15 min.
Mirvat Al Asnag. . KSA
When to use two stents
007002
192
3 11:00 11:15 15 min.
Amr Zaki. Alexandria. Egypt
Learn from cases
007003
67
4 11:15 11:30 15 min.
Maged Ramses. NHI. Egypt
Learn from cases
007004
180
Page | 96
Prepared by RM Solutions | www.rmsolutions.net
97. PROGRAM BY HALL
Al Saraya 1
9
12:30
13:30
Al Saraya 1
EgSCi, Session "9" Optimizing Bifurcation Intervention II, EBC
Joint with EgBC of EgIC "Zoom"
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Abdelrahman Elbokary
Adel Imam
Galal Elsaid
Hossam El Hossary
Kamal Mansour
Khaled Eltohamy
Ramez Guindy
Sherif El Tobgy
1 12:30 12:45 15 min.
Imad Sheiban. . Italy
EBC guidelines and real practice
009001
153
2 12:45 13:00 15 min.
Jacek Legukto. . Poland
How to manage complex side branch access, case based
009002
155
3 13:00 13:15 15 min.
Tamer Abu Arab. Ain Shams. Egypt
Should provisional stenting be the default strategy?
009003
706
4 13:15 13:30 15 min.
Adel El Etriby. Ain Shams. Egypt
Learn from cases
009004
11
Page | 97
Prepared by RM Solutions | www.rmsolutions.net
98. PROGRAM BY HALL
Al Saraya 1
11
14:30
15:30
Al Saraya 1
Session "11" Joint Sessions With SCAI "Zoom"
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Ahmed Elghalid
Ahmed Kamel
Ahmed Magdi
Ahmed Shawky
Hany Ragy
Mohamed Seleem
1 14:30 14:40 10 min.
Cindy Grines. . USA
SCAI Address to Egyptian Society of Cardiology
011001
318
2 14:40 14:55 15 min.
Doane Pinto. . USA
How to plan for successful Intervention
011002
93
3 14:55 15:10 15 min.
Rao Sunil. . USA
Protected PCI
011003
319
4 15:10 15:25 15 min.
Timothy Henry. . USA
Future of anti-platelets
011004
320
5 15:25 15:30 5 min.
Ahmed Magdi. NHI. Egypt
Conclusion
011005
34
Page | 98
Prepared by RM Solutions | www.rmsolutions.net
99. PROGRAM BY HALL
Al Saraya 1
12
15:30
17:00
Al Saraya 1
EgSCi, Session "12" CTO Summit I, Case Based Session
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Abdel Rahman Gamal
Abdelrahman Elbokary
Ahmed Abdel Rahman
Ahmed Ashraf Eissa
Alaa Etman
Emanuele Louka
Hossam Ismail
Mahmoud Abdel khalik
Nabil Farag
1 15:30 15:43 13 min.
Khaled Shokry. Military. Egypt
How to setup CTO program
012001
168
2 15:43 15:56 13 min.
Ahmed Elguindy. AHC. Egypt
IVUS Guided CTO intervention, predictors of success
012002
27
3 15:56 16:09 13 min.
Yasser Sadek. NHI. Egypt
New Tricks for antegrade Approach
012003
309
4 16:09 16:22 13 min.
Tarek Rashid. Ain Shams. Egypt
Which hardware for which lesion
012004
286
5 16:22 16:35 13 min.
Zoltan Ruzsa. . Hungary
My most educational CTO intervention case
012005
312
6 16:35 16:48 13 min.
Hisham Ammar. NHI. Egypt
My most educational CTO intervention case
012006
705
7 16:48 17:01 13 min.
Mahmoud Radwan. NHI. Egypt
My most educational CTO intervention case
012007
327
Page | 99
Prepared by RM Solutions | www.rmsolutions.net
100. PROGRAM BY HALL
Al Saraya 1
13
17:00
18:00
Al Saraya 1
EgSCi, Session "13" Worst Scenario & Best Save Cases
Intervention Ischemia Track Session
Tue 16-2
*
Chairperson
Aysar Abdel Aziz
Essam Mahfouz
Hazem El Guindy
Magdi El Khadem
Mahmoud El Amrousy
Mahmoud Soliman
Yasser Abdel Hady
1 17:00 17:12 12 min.
Hesham Nasr. NHI. Egypt
Case Scenario 1
013001
323
2 17:12 17:24 12 min.
Reda Deyab. Cairo. Egypt
Case Scenario 2
013002
707
3 17:24 17:36 12 min.
Hossam Ismail. Qena. Egypt
Case Scenario 3
013003
147
4 17:36 17:48 12 min.
Mohamed Osman. Sohag. Egypt
Case Scenario 4
013004
414
5 17:48 18:00 12 min.
Ahmed Said. Shebien. Egypt
Case Scenario 5
013005
325
Page | 100
Prepared by RM Solutions | www.rmsolutions.net
101. PROGRAM BY HALL
Al Saraya 1
14
9:00
10:30
Al Saraya 1
EgSCi, Session "14" Optimizing Bifurcation Techniques III case
based session EBC Joint with EgBC of EgIC"
Intervention Ischemia Track Session
Wed 17-2
*
Chairperson
Ahmed Ezz
Amr Elhadidy
Diaa Elmenshawy
Mahmoud Youssef
Mohamed Seleem
Mohamed Zahran
Soliman Ghareeb
1 9:00 9:22 22 min.
Imad Sheiban. . Italy
Lessons for the lesions and patients in Bifurcation intervention
014001
153
2 9:22 9:39 17 min.
Karim Mahmoud. Cairo. Egypt
High risk bifurcation intervention, learn from cases
014002
158
3 9:39 9:56 17 min.
Hesham Bahaa. AHC. Egypt
Learn from cases
014003
139
4 9:56 10:13 17 min.
Abdel Rahman Gamal. NHI. Egypt
Non-Left main bifurcation scenarios
014004
330
5 10:13 10:30 17 min.
Osama Shoeib. Tanta. Egypt
Learn from cases
014005
351
Page | 101
Prepared by RM Solutions | www.rmsolutions.net
102. PROGRAM BY HALL
Al Saraya 1
15
10:30
11:30
Al Saraya 1
EgSCi, Session "15" Optimizing LM Intervention, Rules of
Engagement I EBC Joint with EgBC of EgIC
Intervention Ischemia Track Session
Wed 17-2
*
Chairperson
Ahmed Abdel Rahman
Hosam Hasan
Medhat El-Ashmawy
Osama Refaei
Sherif Sakr
Tamer Moustafa
1 10:30 10:45 15 min.
Hany Ragy. NHI. Egypt
Functional and Anatomic Assessment of Left Main
015001
128
2 10:45 11:00 15 min.
Zoltan Ruzsa. . Hungary
Technical challenges in LM PCI: “Case Based”
015002
312
3 11:00 11:15 15 min.
Mohamed Sadaka. Alexandria. Egypt
Learn from cases
015003
214
4 11:15 11:30 15 min.
Ibrahim Yassin. Azhar. Egypt
Learn from cases
015004
326
Page | 102
Prepared by RM Solutions | www.rmsolutions.net
103. PROGRAM BY HALL
Al Saraya 1
17
12:30
13:30
Al Saraya 1
Session "17" Optimizing LM Intervention II “Cases” EBC Joint with
EgBC of EgIC My Most Challenging Bifurcation Cases, Complex
Intervention Variety Tips
Intervention Ischemia Track Session
Wed 17-2
*
Chairperson
Ayman khairy
Diaa Elmenshawy
Hossam El Hossary
Mohamed El Setiha
Moustafa Mokarrab
Nady Michel
1 12:30 12:45 15 min.
Ayman Aboul Magd. Azhar. Egypt
Case 1: LM Bifurcation what they don’t say
017001
76
2 12:45 13:00 15 min.
Sherif Elbeltagy. Alexandria. Egypt
Case 2: Challenging Left main calcific lesion
017002
271
3 13:00 13:15 15 min.
Shady Hussein. Mansoura. Egypt
Case 3: challenging Left main bifurcation
017003
709
4 13:15 13:30 15 min.
Tamer Moustafa. Zagazig. Egypt
Case 4: LM,Bifurcation scenario
017004
279
Page | 103
Prepared by RM Solutions | www.rmsolutions.net
104. PROGRAM BY HALL
Al Saraya 1
19
14:30
16:00
Al Saraya 1
EgSCi, Session "19" Optimizing LM Intervention III “Concepts”,
EBC Joint with EgBC of EgIC
Intervention Ischemia Track Session
Wed 17-2
*
Chairperson
Ahmed M. Boghdady
Amin Fouad
Essam Mahfouz
Mohamed Korim
Tamer Moustafa
Tarek Zaki
1 14:30 14:45 15 min.
Adam Witkowski. . Poland
Left Main stenting: diameters, strategy and stent choice
019001
9
2 14:45 15:00 15 min.
Jacek Legukto. . Poland
Technical challenges in LM PCI: “Case Based”
019002
155
3 15:00 15:15 15 min.
Nabil Farag. Ain Shams. Egypt
Tips and tricks for challenging cases
019003
229
4 15:15 15:30 15 min.
Amr Kamal. Alexandria. Egypt
Learn from cases
019004
64
5 15:30 15:45 15 min.
Mohamed El Setiha. Tanta. Egypt
Learn from cases, LM Trifurcation
019005
201
6 15:45 16:00 15 min.
Shehab Adel El Etriby. Ain Shams. Egypt
Learn from cases
019006
837
Page | 104
Prepared by RM Solutions | www.rmsolutions.net
105. PROGRAM BY HALL
Al Saraya 1
20
16:00
17:00
Al Saraya 1
EgSCi, Session "20" Optimizing LM Intervention IV “Cases”
EBC Joint with EgBC of EgIC My Most Challenging Bifurcation
Cases, Complex Intervention Variety Tips
Intervention Ischemia Track Session
Wed 17-2
*
Chairperson
Ahmed Wafa
Gamal Fahim Gomea
Hassan Khaled
Hesham Aboul Enien
Khaled Elmeniawy
Medhat El-Ashmawy
1 16:00 16:15 15 min.
Mohamed Lotfy. Alexandria. Egypt
Case 1 Challenging osteal lesions
020001
208
2 16:15 16:30 15 min.
Hossam Mansour. AHC. Egypt
Case 2 :Challenging Case Presentation
020002
850
3 16:30 16:45 15 min.
Moheb Magdy. Mansoura. Egypt
Case 3 Challenging Left main calcific lesion
020003
331
4 16:45 17:00 15 min.
Hadi Abu-Hantash. . Jordan
Case 4 challenging left main cases
020004
708
Page | 105
Prepared by RM Solutions | www.rmsolutions.net